0001270436 Cohen & Co Inc. false
--12-31 Q2 2022 0.001 0.001 50,000,000 50,000,000 27,413,098
27,413,098 27,413,098 27,413,098 0.01 0.01 100,000,000 100,000,000
1,716,942 1,716,942 1,697,443 1,697,443 288,059 366,293 0 0 0 0 0 0
0 0 3 1 0.33 1 0 0 0 86,226 0 0 2 10.00 8.00 5.29 5.15 49,614 1,489
0 2,250 15,000 17,500 25,000 6.0 7.0 10 10 0 10 102,159 10 3 19,357
24 48 The holder of the 2017 Convertible Note may convert all or
any part of the outstanding principal amount at any time priorto
maturity into units of membership interests of the Operating LLC at
a conversion price of $1.45 per unit, subject tocustomary
anti-dilution adjustments. Units of membership interests in the
Operating LLC not held by Cohen & CompanyInc. may, with certain
restrictions, be redeemed and exchanged into shares of the Cohen
& Company Inc. common stock,par value $0.01 per share (“Common
Stock”) on a ten-for-one basis. Therefore, the 2017 Convertible
Note can beconverted into Operating LLC units of membership
interests and then redeemed and exchanged into Common Stock at
aneffective conversion price of $14.50. See note 20 to the Annual
Report on Form 10-K for the year ended December 31,2021. Effective
March 20, 2022, the 2017 Note was converted into 10,344,827 units.
Potentially diluted securities that were not included in the
diluted per share calculations because they would be anti-dilutive
were as follows: Three Months Ended June 30, Six Months Ended June
30, 2022 2021 2022 2021 Unrestricted Operating LLC membership units
exchangeable into Cohen & Company, Inc. shares - 3,504,604 2017
Convertible Note Units - - 448,276 - Restricted Common Stock 87,944
- 84,968 - Restricted Operating LLC units 28,305 - 36,203 - 116,249
- 4,074,051 - Goodwill and intangible assets are allocated to the
Capital Markets and Asset Management business segments as indicated
in the table from above. As a practical expedient, the Company uses
NAV (or its equivalent) to measure the fair value of its
investments in the U.S. Insurance JV, the SPAC Fund and the CREO
JV. The U.S. Insurance JV invests in USD denominated debt issued by
small insurance and reinsurance companies. The SPAC Fund invests in
equity securities of SPACs. The CREO JV invests in primarily
multi-family commercial real estate mortgage-backed loans and
below-investment grade rated tranches in CRE CLOs collateralized by
mostly transitional commercial real estate mortgage-backed loans.
See note 4. According to ASC 820, these investments are not
categorized within the valuation hierarchy. The Operating LLC units
of membership interest not held by Cohen & Company Inc. (that
is, those held by the non-controlling interest) may be redeemed and
exchanged into shares of the Company on a ten-for-one basis. The
Operating LLC units of membership interests not held by Cohen &
Company Inc. are redeemable, at the member’s option at any time,
for (i) cash in an amount equal to the average of the per share
closing prices of the Common Stock for the ten consecutive trading
days immediately preceding the date the Company receives the
member’s redemption notice, or (ii) at the Company’s option, one
tenth of a share of the Common Stock, subject, in each case, to
appropriate adjustment upon the occurrence of an issuance of
additional shares of the Common Stock as a dividend or other
distribution on the outstanding Common Stock, or a further
subdivision or combination of the outstanding shares of the Common
Stock. These units are not included in the computation of basic
earnings per share. These units enter into the computation of
diluted net income (loss) per common share when the effect is not
anti-dilutive using the if-converted method. The CREO JV invests in
primarily multi-family commercial real estate mortgage-backed loans
and below-investment grade rated tranches in CRE CLOs
collateralized by mostly transitional commercial real estate
mortgage-backed loans. See note 4. The SPAC Fund invests in equity
interests of SPACs. Unallocated assets primarily include (1)
amounts due from related parties; (2) furniture and equipment, net;
and (3) other assets that are not considered necessary for an
understanding of business segment assets and such amounts are
excluded in business segment reporting to the chief operating
decision maker. The U.S. Insurance JV invests in USD denominated
debt issued by small and medium sized insurance and reinsurance
companies. Unallocated includes certain expenses incurred by
indirect overhead and support departments (such as the executive,
finance, legal, information technology, human resources, risk,
compliance and other similar overhead and support departments).
Some of the items not allocated include: (1) operating expenses
(such as cash compensation and benefits, equity-based compensation
expense, professional fees, travel and entertainment, consulting
fees, and rent) related to support departments excluding certain
departments that directly support the Capital Markets business
segment; (2) interest expense on debt; and (3) income taxes.
Management does not consider these items necessary for an
understanding of the operating results of these business segments
and such amounts are excluded in business segment reporting to the
chief operating decision maker. An adjustment is included because
the Company would have incurred a higher income tax expense or
realized a higher income tax benefit, as applicable, if the
Operating LLC units of membership interests had been converted at
the beginning of the period. The junior subordinated notes listed
represent debt the Company owes to the two trusts noted above. The
total par amount owed by the Company to the trusts is $49,614.
However, the Company owns the common stock of the trusts in a total
paramount of $1,489. The Company pays interest (and at maturity,
principal) to the trusts on the entire $49,614 junior notes
outstanding. However, the Company receives back from the trusts the
pro rata share of interest and principal on the common stock held
by the Company. These trusts are VIEs and the Company does not
consolidate them even though the Company holds the common stock.
The Company carries the common stock on its balance sheet at a
value of $0. The junior subordinated notes are recorded at a
discount to par. When factoring in the discount, the yield to
maturity of the junior subordinated notes as of June 30, 2022 on a
combined basis was 12.90% assuming the variable rate in effect on
the last day of the reporting period remains in effect until
maturity. Represents the interest rate in effect as of the last day
of the reporting period. 00012704362022-01-012022-06-30
xbrli:shares 00012704362022-08-01 thunderdome:item iso4217:USD
00012704362022-06-30 00012704362021-12-31 iso4217:USDxbrli:shares
00012704362022-04-012022-06-30 00012704362021-04-012021-06-30
00012704362021-01-012021-06-30
0001270436us-gaap:AssetManagement1Member2022-04-012022-06-30
0001270436us-gaap:AssetManagement1Member2021-04-012021-06-30
0001270436us-gaap:AssetManagement1Member2022-01-012022-06-30
0001270436us-gaap:AssetManagement1Member2021-01-012021-06-30
0001270436cohn:NewIssueAndAdvisoryMember2022-04-012022-06-30
0001270436cohn:NewIssueAndAdvisoryMember2021-04-012021-06-30
0001270436cohn:NewIssueAndAdvisoryMember2022-01-012022-06-30
0001270436cohn:NewIssueAndAdvisoryMember2021-01-012021-06-30
0001270436cohn:NoncontrollingInterestOfOperatingLlcMember2022-04-012022-06-30
0001270436cohn:NoncontrollingInterestOfOperatingLlcMember2021-04-012021-06-30
0001270436cohn:NoncontrollingInterestOfOperatingLlcMember2022-01-012022-06-30
0001270436cohn:NoncontrollingInterestOfOperatingLlcMember2021-01-012021-06-30
0001270436cohn:CohenCoIncludingNoncontrollingInterestMember2022-04-012022-06-30
0001270436cohn:CohenCoIncludingNoncontrollingInterestMember2021-04-012021-06-30
0001270436cohn:CohenCoIncludingNoncontrollingInterestMember2022-01-012022-06-30
0001270436cohn:CohenCoIncludingNoncontrollingInterestMember2021-01-012021-06-30
0001270436cohn:NoncontrollingInterestOfCohenCoMember2022-04-012022-06-30
0001270436cohn:NoncontrollingInterestOfCohenCoMember2021-04-012021-06-30
0001270436cohn:NoncontrollingInterestOfCohenCoMember2022-01-012022-06-30
0001270436cohn:NoncontrollingInterestOfCohenCoMember2021-01-012021-06-30
0001270436us-gaap:PreferredStockMember2021-12-31
0001270436us-gaap:CommonStockMember2021-12-31
0001270436us-gaap:AdditionalPaidInCapitalMember2021-12-31
0001270436us-gaap:RetainedEarningsMember2021-12-31
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31
0001270436us-gaap:ParentMember2021-12-31
0001270436us-gaap:NoncontrollingInterestMember2021-12-31
0001270436us-gaap:RetainedEarningsMember2022-01-012022-03-31
0001270436us-gaap:ParentMember2022-01-012022-03-31
0001270436us-gaap:NoncontrollingInterestMember2022-01-012022-03-31
00012704362022-01-012022-03-31
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-31
0001270436us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-31
0001270436us-gaap:PreferredStockMember2022-03-31
0001270436us-gaap:CommonStockMember2022-03-31
0001270436us-gaap:AdditionalPaidInCapitalMember2022-03-31
0001270436us-gaap:RetainedEarningsMember2022-03-31
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-31
0001270436us-gaap:ParentMember2022-03-31
0001270436us-gaap:NoncontrollingInterestMember2022-03-31
00012704362022-03-31
0001270436us-gaap:RetainedEarningsMember2022-04-012022-06-30
0001270436us-gaap:ParentMember2022-04-012022-06-30
0001270436us-gaap:NoncontrollingInterestMember2022-04-012022-06-30
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-30
0001270436us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-30
0001270436us-gaap:PreferredStockMember2022-06-30
0001270436us-gaap:CommonStockMember2022-06-30
0001270436us-gaap:AdditionalPaidInCapitalMember2022-06-30
0001270436us-gaap:RetainedEarningsMember2022-06-30
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-30
0001270436us-gaap:ParentMember2022-06-30
0001270436us-gaap:NoncontrollingInterestMember2022-06-30
0001270436us-gaap:PreferredStockMember2020-12-31
0001270436us-gaap:CommonStockMember2020-12-31
0001270436us-gaap:AdditionalPaidInCapitalMember2020-12-31
0001270436us-gaap:RetainedEarningsMember2020-12-31
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31
0001270436us-gaap:ParentMember2020-12-31
0001270436us-gaap:NoncontrollingInterestMember2020-12-31
00012704362020-12-31
0001270436us-gaap:RetainedEarningsMember2021-01-012021-03-31
0001270436us-gaap:ParentMember2021-01-012021-03-31
0001270436us-gaap:NoncontrollingInterestMember2021-01-012021-03-31
00012704362021-01-012021-03-31
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-31
0001270436us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-31
0001270436us-gaap:PreferredStockMember2021-03-31
0001270436us-gaap:CommonStockMember2021-03-31
0001270436us-gaap:AdditionalPaidInCapitalMember2021-03-31
0001270436us-gaap:RetainedEarningsMember2021-03-31
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-31
0001270436us-gaap:ParentMember2021-03-31
0001270436us-gaap:NoncontrollingInterestMember2021-03-31
00012704362021-03-31
0001270436us-gaap:RetainedEarningsMember2021-04-012021-06-30
0001270436us-gaap:ParentMember2021-04-012021-06-30
0001270436us-gaap:NoncontrollingInterestMember2021-04-012021-06-30
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-30
0001270436us-gaap:CommonStockMember2021-04-012021-06-30
0001270436us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-30
0001270436us-gaap:PreferredStockMember2021-06-30
0001270436us-gaap:CommonStockMember2021-06-30
0001270436us-gaap:AdditionalPaidInCapitalMember2021-06-30
0001270436us-gaap:RetainedEarningsMember2021-06-30
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-30
0001270436us-gaap:ParentMember2021-06-30
0001270436us-gaap:NoncontrollingInterestMember2021-06-30
00012704362021-06-30 xbrli:pure
0001270436us-gaap:CollateralizedDebtObligationsMember2022-06-30
0001270436srt:ScenarioPreviouslyReportedMember2021-12-31
0001270436srt:RestatementAdjustmentMember2021-12-31
0001270436srt:ScenarioPreviouslyReportedMember2021-01-012021-12-31
00012704362021-01-012021-12-31
0001270436srt:RestatementAdjustmentMember2021-01-012021-12-31
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMembercohn:ConvertibleNote2017Member2017-03-10
0001270436cohn:ConvertibleNote2017Membercohn:MembershipUnitsMember2022-03-202022-03-20
0001270436cohn:ConvertibleNote2017Membercohn:MembershipUnitsMember2022-03-20
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMembercohn:JKDCapitalPartnersILTDMember2022-01-312022-01-31
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMembercohn:JKDCapitalPartnersILTDMember2022-01-31
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMembercohn:JKDCapitalPartnersILtdAndRNCapitalSolutionsLLCMember2022-02-012022-03-31
0001270436cohn:CREOJVMember2021-09-03
0001270436cohn:CREOJVMember2021-09-032021-09-03
0001270436cohn:CREOJVMember2021-09-03
0001270436cohn:CREOJVMember2022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2020-12-222020-12-22
0001270436cohn:InsuranceSPACIIISponsorEntitiesMemberus-gaap:OverAllotmentOptionMember2020-12-222020-12-22
0001270436cohn:InsuranceSPACIIIMember2020-09-082020-12-22
0001270436cohn:InsuranceSPACIIIMember2020-12-22
0001270436cohn:WarrantsForSPACIICommonStockMembercohn:InsuranceSPACIIIMember2020-12-22
0001270436cohn:InsuranceSpacWarrantIIIMembercohn:InsuranceSPACMember2020-12-222020-12-22
utr:D
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2020-12-22
0001270436cohn:InsuranceSPACIIISponsorEntitiesMemberus-gaap:OverAllotmentOptionMember2020-12-212020-12-21
0001270436cohn:InsuranceSPACIIISponsorEntitiesMemberus-gaap:PrivatePlacementMember2020-12-222020-12-22
0001270436cohn:InsuranceSPACIIISponsorEntitiesMemberus-gaap:IPOMember2020-12-222020-12-22
0001270436cohn:InsuranceSPACIIISponsorEntitiesMemberus-gaap:IPOMember2020-12-22
0001270436cohn:FounderSharesMembercohn:InsuranceSPACIIISponsorEntitiesMember2020-12-22
0001270436cohn:FounderSharesMembercohn:InsuranceSPACIIISponsorEntitiesMember2020-12-222020-12-22
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-01-012022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-06-30
0001270436cohn:InsuranceSPACIIIMember2022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-06-30
0001270436us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-06-30
0001270436us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-31
0001270436us-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-30
0001270436us-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-31
0001270436us-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:USTreasurySecuritiesMember2022-06-30
0001270436us-gaap:USTreasurySecuritiesMember2021-12-31
0001270436us-gaap:AssetBackedSecuritiesMember2022-06-30
0001270436us-gaap:AssetBackedSecuritiesMember2021-12-31
0001270436cohn:CorporateBondsAndRedeemablePreferredStockMember2022-06-30
0001270436cohn:CorporateBondsAndRedeemablePreferredStockMember2021-12-31
0001270436cohn:ForeignGovernmentBondsMember2022-06-30
0001270436cohn:ForeignGovernmentBondsMember2021-12-31
0001270436us-gaap:MunicipalBondsMember2022-06-30
0001270436us-gaap:MunicipalBondsMember2021-12-31
0001270436us-gaap:CertificatesOfDepositMember2022-06-30
0001270436us-gaap:CertificatesOfDepositMember2021-12-31
0001270436us-gaap:DerivativeMember2022-06-30
0001270436us-gaap:DerivativeMember2021-12-31
0001270436us-gaap:EquitySecuritiesMember2022-06-30
0001270436us-gaap:EquitySecuritiesMember2021-12-31
0001270436cohn:RestrictedEquitySecuritiesMember2022-06-30
0001270436cohn:RestrictedEquitySecuritiesMember2021-12-31
0001270436cohn:CorporateBondsAndRedeemablePreferredStockMember2022-06-30
0001270436cohn:CorporateBondsAndRedeemablePreferredStockMember2021-12-31
0001270436cohn:CREOJVMember2022-06-30
0001270436cohn:CREOJVMember2021-12-31
0001270436cohn:USInsuranceJVMember2022-06-30
0001270436cohn:USInsuranceJVMember2021-12-31
0001270436cohn:SPACFundMember2022-06-30
0001270436cohn:SPACFundMember2021-12-31
0001270436us-gaap:ResidentialMortgageMember2022-06-30
0001270436us-gaap:ResidentialMortgageMember2021-12-31
0001270436cohn:MarginLoanCollateralMember2022-06-30
0001270436cohn:MarginLoanCollateralMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2022-06-30
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2022-06-30
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2022-06-30
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2022-06-30
0001270436us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-30
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:CorporateBondsAndRedeemablePreferredStockMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:ForeignGovernmentBondsMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MunicipalBondsMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:RestrictedEquitySecuritiesMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageMember2021-12-31
0001270436us-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2021-12-31
0001270436us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2021-12-31
0001270436us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2021-12-31
0001270436us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembercohn:TotalInvestmentsNotMeasuredAtNavMember2021-12-31
0001270436us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-31
0001270436cohn:SPACFundMember2022-01-012022-06-30
0001270436cohn:SPACFundMember2021-01-012021-12-31
0001270436cohn:TBAAndOtherForwardMbsMemberus-gaap:LongMember2022-06-30
0001270436cohn:TBAAndOtherForwardMbsMemberus-gaap:ShortMember2022-06-30
0001270436cohn:TBAAndOtherForwardMbsMemberus-gaap:LongMember2021-12-31
0001270436cohn:TBAAndOtherForwardMbsMemberus-gaap:ShortMember2021-12-31
0001270436cohn:OtherExtendedSettlementTradeMemberus-gaap:LongMember2022-06-30
0001270436cohn:OtherExtendedSettlementTradeMemberus-gaap:LongMember2021-12-31
0001270436us-gaap:ForeignExchangeForwardMember2022-06-30
0001270436us-gaap:ForeignExchangeForwardMember2021-12-31
0001270436cohn:InvestmentsTradingMembercohn:TBAAndOtherForwardMbsMemberus-gaap:LongMember2022-06-30
0001270436cohn:InvestmentsTradingMembercohn:TBAAndOtherForwardMbsMemberus-gaap:LongMember2021-12-31
0001270436cohn:TradingSecuritiesSoldNotYetPurchasedMembercohn:TBAAndOtherForwardMbsMemberus-gaap:ShortMember2022-06-30
0001270436cohn:TradingSecuritiesSoldNotYetPurchasedMembercohn:TBAAndOtherForwardMbsMemberus-gaap:ShortMember2021-12-31
0001270436cohn:OtherExtendedSettlementTradeMembercohn:RevenueNetTradingMember2021-04-012021-06-30
0001270436cohn:TBAAndOtherForwardMbsMembercohn:RevenueNetTradingMember2022-04-012022-06-30
0001270436cohn:TBAAndOtherForwardMbsMembercohn:RevenueNetTradingMember2021-04-012021-06-30
0001270436cohn:OtherExtendedSettlementTradeMembercohn:PrincipalTransactionsAndOtherIncomeMember2021-04-012021-06-30
0001270436cohn:OtherExtendedSettlementTradeMembercohn:RevenueNetTradingMember2021-01-012021-06-30
0001270436cohn:TBAAndOtherForwardMbsMembercohn:RevenueNetTradingMember2022-01-012022-06-30
0001270436cohn:TBAAndOtherForwardMbsMembercohn:RevenueNetTradingMember2021-01-012021-06-30
0001270436cohn:OtherExtendedSettlementTradeMembercohn:PrincipalTransactionsAndOtherIncomeMember2021-01-012021-06-30
0001270436cohn:FifthThirdFinancialBankMember2018-04-25
0001270436cohn:FirstGuarantyMortgageCorporationMember2022-06-30
0001270436cohn:FirstGuarantyMortgageCorporationMemberus-gaap:SubsequentEventMember2022-07-012022-08-02
0001270436cohn:FirstGuarantyMortgageCorporationMemberus-gaap:SubsequentEventMember2022-08-02
0001270436cohn:GCFRepoBusinessMember2022-06-30
0001270436cohn:GestationalRepoBusinessMember2022-06-30
0001270436cohn:GestationalRepoBusinessMember2021-12-31
0001270436cohn:GestationalRepoBusinessMember2022-04-012022-06-30
0001270436cohn:GestationalRepoBusinessMember2021-04-012021-06-30
0001270436cohn:GestationalRepoBusinessMember2022-01-012022-06-30
0001270436cohn:GestationalRepoBusinessMember2021-01-012021-06-30
0001270436cohn:OvernightAndContinuousMemberus-gaap:MortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:MaturityUpTo30DaysMemberus-gaap:MortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:Maturity30To90DaysMemberus-gaap:MortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:MaturityOver90DaysMemberus-gaap:MortgageBackedSecuritiesMember2022-06-30
0001270436us-gaap:MortgageBackedSecuritiesMember2022-06-30
0001270436cohn:OvernightAndContinuousMember2022-06-30
0001270436us-gaap:MaturityUpTo30DaysMember2022-06-30
0001270436us-gaap:Maturity30To90DaysMember2022-06-30
0001270436us-gaap:MaturityOver90DaysMember2022-06-30
0001270436us-gaap:MaturityUpTo30DaysMemberus-gaap:MortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:Maturity30To90DaysMemberus-gaap:MortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:MaturityOver90DaysMemberus-gaap:MortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:MortgageBackedSecuritiesMember2021-12-31
0001270436us-gaap:MaturityUpTo30DaysMember2021-12-31
0001270436us-gaap:Maturity30To90DaysMember2021-12-31
0001270436us-gaap:MaturityOver90DaysMember2021-12-31
0001270436cohn:InsuranceSPACMember2021-12-31
0001270436cohn:DutchRealEstateEntitiesMember2021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMember2021-12-31
0001270436cohn:InsuranceSPACMember2022-01-012022-06-30
0001270436cohn:DutchRealEstateEntitiesMember2022-01-012022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2022-01-012022-06-30
0001270436cohn:InsuranceSPACMember2022-06-30
0001270436cohn:DutchRealEstateEntitiesMember2022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2022-06-30
0001270436cohn:InsuranceSPACMember2020-12-31
0001270436cohn:DutchRealEstateEntitiesMember2020-12-31
0001270436cohn:OtherSpacSponsorEntitiesMember2020-12-31
0001270436cohn:InsuranceSPACMember2021-01-012021-12-31
0001270436cohn:DutchRealEstateEntitiesMember2021-01-012021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMember2021-01-012021-12-31
0001270436cohn:ArchrMember2022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:WejoMember2022-06-30
0001270436cohn:AlphaTauMedicalMember2022-06-30
0001270436cohn:ParellaWeinbergPartnersMember2022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:VariousOtherSponsorEntitiesMember2022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:PwpMember2021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:ArchrMember2021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:WejoMember2021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:HlgnMember2021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMembercohn:VariousOtherSponsorEntitiesMember2021-12-31
0001270436cohn:OtherSpacSponsorEntitiesMember2021-12-31 utr:Y
0001270436cohn:FurnitureEquipmentAndLeaseholdImprovementsMember2022-06-30
0001270436cohn:FurnitureEquipmentAndLeaseholdImprovementsMember2021-12-31
0001270436us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-06-30
0001270436us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-31
0001270436us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-06-30
0001270436us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-12-31
0001270436cohn:JKDCapitalPartnersILTDMember2022-06-30
0001270436cohn:JKDCapitalPartnersILTDMember2021-12-31
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:ContingentConvertibleSeniorNotesMember2022-06-30
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:ContingentConvertibleSeniorNotesMember2021-12-31
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMembercohn:ContingentConvertibleSeniorNotesMember2022-06-30
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMembercohn:ContingentConvertibleSeniorNotesMember2021-12-31
0001270436cohn:ContingentConvertibleSeniorNotesMember2022-06-30
0001270436cohn:ContingentConvertibleSeniorNotesMember2021-12-31
0001270436cohn:AlescoCapitalTrustIMembercohn:JuniorSubordinatedNotesMember2022-06-30
0001270436cohn:AlescoCapitalTrustIMembercohn:JuniorSubordinatedNotesMember2021-12-31
0001270436cohn:SunsetFinancialStatutoryTrustIMembercohn:JuniorSubordinatedNotesMember2022-06-30
0001270436cohn:SunsetFinancialStatutoryTrustIMembercohn:JuniorSubordinatedNotesMember2021-12-31
0001270436cohn:JuniorSubordinatedNotesMember2022-06-30
0001270436cohn:JuniorSubordinatedNotesMember2021-12-31
0001270436cohn:BylineBankMembercohn:CreditFacilityMember2022-06-30
0001270436cohn:BylineBankMembercohn:CreditFacilityMember2021-12-31
0001270436cohn:ConvertibleNote2017Membercohn:MembershipUnitsMember2022-06-30
0001270436cohn:ConvertibleNote2017Memberus-gaap:CommonStockMember2022-03-20
0001270436us-gaap:JuniorSubordinatedDebtMember2022-06-30
0001270436cohn:SunsetFinancialStatutoryTrustIMemberus-gaap:JuniorSubordinatedDebtMembercohn:AlescoCapitalTrustIMember2022-06-30
0001270436us-gaap:JuniorSubordinatedDebtMember2021-01-012021-06-30
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMembercohn:JKDCapitalPartnersILTDMember2020-01-31
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMember2020-01-31
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMembercohn:RNCapitalSolutionsLLCRNCSMember2020-01-31
0001270436cohn:NonconvertibleSeniorNotes10002020SeniorNotesMembercohn:NonconvertibleSeniorNotesMembercohn:JKDCapitalPartnersILTDMember2022-06-30
0001270436cohn:ConvertibleNote2017Member2017-03-10
0001270436cohn:AlescoCapitalTrustIDebtMembercohn:JuniorSubordinatedNotesMember2022-06-30
0001270436cohn:AlescoCapitalTrustIDebtMembercohn:JuniorSubordinatedNotesMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-06-30
0001270436cohn:CohenCompanyMembercohn:AlescoCapitalTrustIMember2022-01-012022-06-30
0001270436cohn:SunsetFinancialStatutoryTrustIDebtMembercohn:JuniorSubordinatedNotesMember2022-06-30
0001270436cohn:SunsetFinancialStatutoryTrustIDebtMembercohn:JuniorSubordinatedNotesMember2022-01-012022-06-30
0001270436cohn:CohenCompanyMembercohn:SunsetFinancialStatutoryTrustIMember2022-01-012022-06-30
0001270436cohn:CommonSecuritiesInTrustsMember2022-06-30
0001270436cohn:OriginalBylineLoanAgreementMember2020-10-28
0001270436cohn:OriginalBylineNoteAndSubordinationAgreementMember2020-10-28
0001270436cohn:AmendedAndRestatedBylineLoanAgreementMember2021-12-31
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-12-212021-12-21
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-10-28
0001270436cohn:JVBMembercohn:BylineBankMembercohn:CreditFacilityMember2020-10-282020-10-28
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMember2020-10-28
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMember2020-10-282020-10-28
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMember2021-12-212021-12-21
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMember2021-12-21
0001270436cohn:JVBHoldingsMembercohn:JVBMember2020-10-28
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMembercohn:December302021ThroughDecember312022Member2020-10-28
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMembercohn:AfterDecember312022Member2020-10-28
0001270436cohn:CreditFacilityMembercohn:JVBMembercohn:BylineBankMember2022-06-30
0001270436cohn:JuniorSubordinatedNotesMember2022-04-012022-06-30
0001270436cohn:JuniorSubordinatedNotesMember2021-04-012021-06-30
0001270436cohn:JuniorSubordinatedNotesMember2022-01-012022-06-30
0001270436cohn:JuniorSubordinatedNotesMember2021-01-012021-06-30
0001270436cohn:SeniorNote2020Member2022-04-012022-06-30
0001270436cohn:SeniorNote2020Member2021-04-012021-06-30
0001270436cohn:SeniorNote2020Member2022-01-012022-06-30
0001270436cohn:SeniorNote2020Member2021-01-012021-06-30
0001270436cohn:ConvertibleNote2017Member2022-04-012022-06-30
0001270436cohn:ConvertibleNote2017Member2021-04-012021-06-30
0001270436cohn:ConvertibleNote2017Member2022-01-012022-06-30
0001270436cohn:ConvertibleNote2017Member2021-01-012021-06-30
0001270436cohn:Convertible2013Notes2019SeniorNotesMember2022-04-012022-06-30
0001270436cohn:Convertible2013Notes2019SeniorNotesMember2021-04-012021-06-30
0001270436cohn:Convertible2013Notes2019SeniorNotesMember2022-01-012022-06-30
0001270436cohn:Convertible2013Notes2019SeniorNotesMember2021-01-012021-06-30
0001270436cohn:BylineBankCreditFacilityMember2022-04-012022-06-30
0001270436cohn:BylineBankCreditFacilityMember2021-04-012021-06-30
0001270436cohn:BylineBankCreditFacilityMember2022-01-012022-06-30
0001270436cohn:BylineBankCreditFacilityMember2021-01-012021-06-30
0001270436cohn:RedeemableFinancialInstrumentDgcFamilyFintechTrustCbfMember2022-04-012022-06-30
0001270436cohn:RedeemableFinancialInstrumentDgcFamilyFintechTrustCbfMember2021-04-012021-06-30
0001270436cohn:RedeemableFinancialInstrumentDgcFamilyFintechTrustCbfMember2022-01-012022-06-30
0001270436cohn:RedeemableFinancialInstrumentDgcFamilyFintechTrustCbfMember2021-01-012021-06-30
0001270436cohn:RedeemableFinancialInstrumentJkdCapitalPartnersILtdMember2022-04-012022-06-30
0001270436cohn:RedeemableFinancialInstrumentJkdCapitalPartnersILtdMember2021-04-012021-06-30
0001270436cohn:RedeemableFinancialInstrumentJkdCapitalPartnersILtdMember2022-01-012022-06-30
0001270436cohn:RedeemableFinancialInstrumentJkdCapitalPartnersILtdMember2021-01-012021-06-30
0001270436cohn:CohenCompanyMemberus-gaap:CommonStockMember2021-12-31
0001270436cohn:CohenCompanyMemberus-gaap:CommonStockMember2022-01-012022-06-30
0001270436cohn:CohenCompanyMemberus-gaap:CommonStockMember2022-06-30
0001270436us-gaap:SeriesEPreferredStockMember2022-01-012022-06-30
0001270436us-gaap:SeriesEPreferredStockMember2022-06-30
0001270436us-gaap:SeriesFPreferredStockMember2019-12-23
0001270436cohn:MrCohenMemberus-gaap:SeriesFPreferredStockMember2019-12-232019-12-23
0001270436cohn:DGCTrustMemberus-gaap:SeriesFPreferredStockMember2019-12-232019-12-23
0001270436us-gaap:SeriesFPreferredStockMember2019-12-232019-12-23
0001270436us-gaap:SeriesFPreferredStockMember2021-06-30
0001270436us-gaap:CommonStockMember2022-04-012022-06-30
0001270436us-gaap:CommonStockMember2022-01-012022-06-30
0001270436us-gaap:CommonStockMember2021-04-012021-06-30
0001270436us-gaap:CommonStockMember2021-01-012021-06-30
0001270436cohn:SeriesCJuniorParticipatingPreferredStockMember2020-03-10
0001270436cohn:SeriesCJuniorParticipatingPreferredStockMember2020-03-102020-03-10
0001270436cohn:The2020RightsAgreementMember2020-03-102020-03-10
0001270436cohn:The2020RightsAgreementMember2020-03-10
00012704362020-03-10
0001270436cohn:UnitIssuanceAndSurrenderAgreementMember2022-01-012022-06-30
0001270436us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-30
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-30
0001270436us-gaap:NoncontrollingInterestMember2022-01-012022-06-30
0001270436cohn:TheDecember2020LetterAgreementMember2020-12-31
0001270436cohn:The10b51PlanMember2021-04-012021-06-30
0001270436cohn:The10b51PlanMember2021-01-012021-06-30
0001270436cohn:NorthlandCapitalMarketsMembersrt:MaximumMembercohn:EquityAgreementMember2020-12-01
0001270436cohn:NorthlandCapitalMarketsMembercohn:EquityAgreementMember2021-03-05
0001270436cohn:EquityDistributionLetterAgreementMember2021-06-07
0001270436cohn:EquityDistributionLetterAgreementMember2021-04-012021-06-30
0001270436cohn:EquityDistributionLetterAgreementMember2021-01-012021-06-30
0001270436cohn:EquityDistributionLetterAgreementMember2021-01-012021-12-31
0001270436cohn:EquityDistributionLetterAgreementMember2022-01-012022-06-30
0001270436cohn:OperatingLLCMember2021-12-31
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2021-12-31
0001270436cohn:OtherConsolidatedSubsidiariesMember2021-12-31
0001270436cohn:OperatingLLCMember2022-01-012022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-01-012022-06-30
0001270436cohn:OtherConsolidatedSubsidiariesMember2022-01-012022-06-30
0001270436cohn:OperatingLLCMember2022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-06-30
0001270436cohn:OtherConsolidatedSubsidiariesMember2022-06-30
0001270436cohn:OperatingLLCMember2022-06-30
0001270436cohn:RemainingNoncontrollingMembersMembercohn:OperatingLLCMember2022-06-30
0001270436cohn:JVBMember2022-06-30
0001270436cohn:CCFESAMember2022-06-30
0001270436cohn:ConvertibleNoncontrollingInterestOfCohenCoMember2022-04-012022-06-30
0001270436cohn:ConvertibleNoncontrollingInterestOfCohenCoMember2021-04-012021-06-30
0001270436cohn:ConvertibleNoncontrollingInterestOfCohenCoMember2022-01-012022-06-30
0001270436cohn:ConvertibleNoncontrollingInterestOfCohenCoMember2021-01-012021-06-30
0001270436cohn:UnrestrictedOperatingLlcUnitsExchangeableIntoCohenSharesMember2022-04-012022-06-30
0001270436cohn:UnrestrictedOperatingLlcUnitsExchangeableIntoCohenSharesMember2021-04-012021-06-30
0001270436cohn:UnrestrictedOperatingLlcUnitsExchangeableIntoCohenSharesMember2022-01-012022-06-30
0001270436cohn:UnrestrictedOperatingLlcUnitsExchangeableIntoCohenSharesMember2021-01-012021-06-30
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMember2022-04-012022-06-30
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMember2021-04-012021-06-30
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMember2022-01-012022-06-30
0001270436cohn:ContingentConvertibleSeniorNotes8002017ConvertibleNoteMember2021-01-012021-06-30
0001270436us-gaap:RestrictedStockMember2022-04-012022-06-30
0001270436us-gaap:RestrictedStockMember2021-04-012021-06-30
0001270436us-gaap:RestrictedStockMember2022-01-012022-06-30
0001270436us-gaap:RestrictedStockMember2021-01-012021-06-30
0001270436cohn:RestrictedOperatingLlcUnitsMember2022-04-012022-06-30
0001270436cohn:RestrictedOperatingLlcUnitsMember2021-04-012021-06-30
0001270436cohn:RestrictedOperatingLlcUnitsMember2022-01-012022-06-30
0001270436cohn:RestrictedOperatingLlcUnitsMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:CapitalMarketsMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:AssetManagementSegmentMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:PrincipalInvestingMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMember2022-01-012022-06-30
0001270436us-gaap:MaterialReconcilingItemsMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:CapitalMarketsMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:AssetManagementSegmentMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:PrincipalInvestingMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Member2022-01-012022-06-30
0001270436us-gaap:MaterialReconcilingItemsMemberus-gaap:AssetManagement1Member2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:CapitalMarketsMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:AssetManagementSegmentMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:PrincipalInvestingMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMember2022-01-012022-06-30
0001270436us-gaap:MaterialReconcilingItemsMembercohn:NewIssueAndAdvisoryMember2022-01-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:CapitalMarketsMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:AssetManagementSegmentMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:PrincipalInvestingMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMember2021-01-012021-06-30
0001270436us-gaap:MaterialReconcilingItemsMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:CapitalMarketsMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:AssetManagementSegmentMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:PrincipalInvestingMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Member2021-01-012021-06-30
0001270436us-gaap:MaterialReconcilingItemsMemberus-gaap:AssetManagement1Member2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:CapitalMarketsMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:AssetManagementSegmentMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:PrincipalInvestingMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMember2021-01-012021-06-30
0001270436us-gaap:MaterialReconcilingItemsMembercohn:NewIssueAndAdvisoryMember2021-01-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:CapitalMarketsMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:AssetManagementSegmentMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:PrincipalInvestingMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMember2022-04-012022-06-30
0001270436us-gaap:MaterialReconcilingItemsMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:CapitalMarketsMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:AssetManagementSegmentMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:PrincipalInvestingMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Member2022-04-012022-06-30
0001270436us-gaap:MaterialReconcilingItemsMemberus-gaap:AssetManagement1Member2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:CapitalMarketsMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:AssetManagementSegmentMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:PrincipalInvestingMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMember2022-04-012022-06-30
0001270436us-gaap:MaterialReconcilingItemsMembercohn:NewIssueAndAdvisoryMember2022-04-012022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:CapitalMarketsMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:AssetManagementSegmentMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:PrincipalInvestingMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMember2021-04-012021-06-30
0001270436us-gaap:MaterialReconcilingItemsMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:CapitalMarketsMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:AssetManagementSegmentMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Membercohn:PrincipalInvestingMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMemberus-gaap:AssetManagement1Member2021-04-012021-06-30
0001270436us-gaap:MaterialReconcilingItemsMemberus-gaap:AssetManagement1Member2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:CapitalMarketsMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:AssetManagementSegmentMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMembercohn:PrincipalInvestingMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:NewIssueAndAdvisoryMember2021-04-012021-06-30
0001270436us-gaap:MaterialReconcilingItemsMembercohn:NewIssueAndAdvisoryMember2021-04-012021-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:CapitalMarketsMember2022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:AssetManagementSegmentMember2022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:PrincipalInvestingMember2022-06-30
0001270436us-gaap:OperatingSegmentsMember2022-06-30
0001270436us-gaap:MaterialReconcilingItemsMember2022-06-30
0001270436us-gaap:OperatingSegmentsMembercohn:CapitalMarketsMember2021-12-31
0001270436us-gaap:OperatingSegmentsMembercohn:AssetManagementSegmentMember2021-12-31
0001270436us-gaap:OperatingSegmentsMembercohn:PrincipalInvestingMember2021-12-31
0001270436us-gaap:OperatingSegmentsMember2021-12-31
0001270436us-gaap:MaterialReconcilingItemsMember2021-12-31
0001270436country:US2022-04-012022-06-30
0001270436country:US2021-04-012021-06-30
0001270436country:US2022-01-012022-06-30
0001270436country:US2021-01-012021-06-30
0001270436cohn:UnitedKingdomOtherMember2022-04-012022-06-30
0001270436cohn:UnitedKingdomOtherMember2021-04-012021-06-30
0001270436cohn:UnitedKingdomOtherMember2022-01-012022-06-30
0001270436cohn:UnitedKingdomOtherMember2021-01-012021-06-30
0001270436cohn:InKindDistributionFromEquityMethodAffiliateMember2022-01-012022-06-30
0001270436cohn:DistributionRelatingToTheSPACMergerMember2022-01-012022-06-30
0001270436cohn:InvestmentReclassMember2022-01-012022-06-30
0001270436us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-30
0001270436us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-30
0001270436us-gaap:NoncontrollingInterestMember2021-01-012021-06-30
0001270436cohn:DistributionSettlementWithVellarGPMember2021-01-012021-06-30
0001270436cohn:MetromileMergerDistributionMember2021-01-012021-06-30
0001270436cohn:DistributionRelatingToTheSPACMergerMember2021-01-012021-06-30
0001270436cohn:InkindDistributionFromInsuranceSPACMergerMember2021-01-012021-06-30
0001270436cohn:CBFCohenBrosFinancialMember2017-09-292017-09-29
0001270436cohn:DGCTrustCBFMember2017-09-292017-09-29
0001270436cohn:DGCTrustCBFMember2021-03-012021-03-31
0001270436cohn:DGCTrustCBFMember2020-10-012020-10-31
0001270436cohn:EbcFamilyTrustMember2013-09-012013-09-30
0001270436cohn:EbcFamilyTrustMember2013-09-30
0001270436cohn:JKDCapitalPartnersILTDMember2016-10-032016-10-03
0001270436cohn:JKDCapitalPartnersILTDMember2017-01-012017-01-31
0001270436cohn:JKDCapitalPartnersILTDMember2019-01-012019-01-31
0001270436cohn:JKDCapitalPartnersILTDMember2020-01-312020-01-31
0001270436cohn:NotePurchaseAgreementMembercohn:JKDCapitalPartnersILTDMember2022-01-312022-01-31
0001270436cohn:JKDCapitalPartnersILTDMember2022-01-312022-01-31
00012704362022-03-20 0001270436cohn:FintechMasalaMember2018-07-31
0001270436cohn:FintechMasalaMember2020-10-01
0001270436cohn:BetsyCohenMembercohn:SPACIISponsorEntitiesMember2020-01-012020-12-31
0001270436cohn:FliposMember2021-12-31
0001270436cohn:CKCapitalPartnersBvMember2019-12-31
0001270436cohn:DanielGCohenMembercohn:CKCapitalPartnersBvMember2019-12-31
0001270436cohn:AOIMember2019-12-31
0001270436cohn:OperatingLLCMembercohn:InsuranceSPACIIMember2021-02-08
0001270436cohn:OperatingLLCMembercohn:InsuranceSPACIIMember2022-06-30
0001270436cohn:InsuranceSPACIIMember2022-06-30
0001270436cohn:OperatingLLCMembercohn:InsuranceSPACIIISponsorEntitiesMember2022-06-30
0001270436cohn:InsuranceSPACIIIMember2022-01-012022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-01-012022-06-30
0001270436cohn:InsuranceSPACIIISponsorEntitiesMember2022-06-30
0001270436cohn:SPACFundMember2022-06-30
0001270436cohn:OperatingLLCMembercohn:USInsuranceJVMember2022-06-30
0001270436cohn:OperatingLLCMembercohn:CREOJVMember2022-06-30
0001270436cohn:FounderSharesMembercohn:FTACIVSponsorMember2020-09-292020-09-29
0001270436cohn:FTACIVSponsorMember2020-12-31
0001270436cohn:FTACIVSponsorMember2020-09-292020-09-29
0001270436cohn:FTACOlympusMember2020-12-31
0001270436cohn:FounderSharesMembercohn:FTACIVSponsorMember2020-12-142020-12-14
0001270436cohn:FTACVSponsorMember2020-12-142020-12-14
0001270436cohn:FTACVSponsorMember2020-12-14
0001270436cohn:FTACOlympusSponsorMember2021-06-262021-06-26
0001270436cohn:FTACOlympusSponsorMember2021-06-26
0001270436cohn:FTACOlympusSponsorMember2020-09-082020-09-08
0001270436cohn:FTACOlympusSponsorMember2020-09-08
0001270436cohn:FTACAthenaSponsorMember2021-02-262021-02-26
0001270436cohn:FTACAthenaSponsorMember2021-02-26
0001270436cohn:FTACHeraSponsorMember2021-03-052021-03-05
0001270436cohn:FTACHeraSponsorMember2021-03-05
0001270436cohn:FTACParnassusSponsorMember2021-03-152021-03-15
0001270436cohn:FTACParnassusSponsorMember2021-03-15
0001270436cohn:FTACZeusSponsorMember2021-11-242021-11-24
0001270436cohn:FTACZeusSponsorMember2021-11-24
0001270436cohn:FTACEmeraldSponsorMember2021-12-202021-12-20
0001270436cohn:FTACHeraSponsorMember2021-12-20
0001270436cohn:OtherInvestmentMember2022-06-30
0001270436cohn:SPACFundMember2022-04-012022-06-30
0001270436cohn:SPACFundMember2021-04-012021-06-30
0001270436cohn:SPACFundMember2022-01-012022-06-30
0001270436cohn:SPACFundMember2021-01-012021-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2022-04-012022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2021-04-012021-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2022-01-012022-06-30
0001270436cohn:OtherSpacSponsorEntitiesMember2021-01-012021-06-30
0001270436cohn:USInsuranceJVMember2022-04-012022-06-30
0001270436cohn:USInsuranceJVMember2021-04-012021-06-30
0001270436cohn:USInsuranceJVMember2022-01-012022-06-30
0001270436cohn:USInsuranceJVMember2021-01-012021-06-30
0001270436cohn:InsuranceSPACIIMember2022-04-012022-06-30
0001270436cohn:InsuranceSPACIIMember2021-04-012021-06-30
0001270436cohn:InsuranceSPACIIMember2022-01-012022-06-30
0001270436cohn:InsuranceSPACIIMember2021-01-012021-06-30
0001270436cohn:InsuranceSPACIIIMember2022-04-012022-06-30
0001270436cohn:InsuranceSPACIIIMember2021-04-012021-06-30
0001270436cohn:InsuranceSPACIIIMember2021-01-012021-06-30
0001270436cohn:FliposMember2022-04-012022-06-30
0001270436cohn:FliposMember2021-04-012021-06-30
0001270436cohn:FliposMember2022-01-012022-06-30
0001270436cohn:FliposMember2021-01-012021-06-30
0001270436cohn:CREOJVMember2022-04-012022-06-30
0001270436cohn:CREOJVMember2021-04-012021-06-30
0001270436cohn:CREOJVMember2022-01-012022-06-30
0001270436cohn:CREOJVMember2021-01-012021-06-30
0001270436cohn:DutchRealEstateEntitiesMember2022-04-012022-06-30
0001270436cohn:DutchRealEstateEntitiesMember2021-04-012021-06-30
0001270436cohn:DutchRealEstateEntitiesMember2022-01-012022-06-30
0001270436cohn:DutchRealEstateEntitiesMember2021-01-012021-06-30
0001270436cohn:OtherSpacEntitiesMember2022-04-012022-06-30
0001270436cohn:OtherSpacEntitiesMember2021-04-012021-06-30
0001270436cohn:OtherSpacEntitiesMember2022-01-012022-06-30
0001270436cohn:OtherSpacEntitiesMember2021-01-012021-06-30
0001270436cohn:DuaneMorrisMember2022-04-012022-06-30
0001270436cohn:DuaneMorrisMember2021-04-012021-06-30
0001270436cohn:DuaneMorrisMember2022-01-012022-06-30
0001270436cohn:DuaneMorrisMember2021-01-012021-06-30
0001270436cohn:FintechMasalaLLCMember2022-04-012022-06-30
0001270436cohn:FintechMasalaLLCMember2021-04-012021-06-30
0001270436cohn:FintechMasalaLLCMember2022-01-012022-06-30
0001270436cohn:FintechMasalaLLCMember2021-01-012021-06-30
0001270436cohn:CBFMember2022-04-012022-06-30
0001270436cohn:CBFMember2021-04-012021-06-30
0001270436cohn:CBFMember2022-01-012022-06-30
0001270436cohn:CBFMember2021-01-012021-06-30
0001270436cohn:DGCTrustMember2022-04-012022-06-30
0001270436cohn:DGCTrustMember2021-04-012021-06-30
0001270436cohn:DGCTrustMember2022-01-012022-06-30
0001270436cohn:DGCTrustMember2021-01-012021-06-30
0001270436cohn:EbcMember2022-04-012022-06-30
0001270436cohn:EbcMember2021-04-012021-06-30
0001270436cohn:EbcMember2022-01-012022-06-30
0001270436cohn:EbcMember2021-01-012021-06-30
0001270436cohn:JKDInvestorMember2022-04-012022-06-30
0001270436cohn:JKDInvestorMember2021-04-012021-06-30
0001270436cohn:JKDInvestorMember2022-01-012022-06-30
0001270436cohn:JKDInvestorMember2021-01-012021-06-30
0001270436cohn:SavingPlan401kMember2022-01-012022-06-30
0001270436cohn:ZuckerAndMooreLlcMember2022-04-012022-06-30
0001270436cohn:ZuckerAndMooreLlcMember2021-04-012021-06-30
0001270436cohn:ZuckerAndMooreLlcMember2022-01-012022-06-30
0001270436cohn:ZuckerAndMooreLlcMember2021-01-012021-06-30
0001270436cohn:CKCapitalPartnersBvMember2022-06-30
0001270436cohn:CKCapitalPartnersBvMember2021-12-31
0001270436cohn:USInsuranceJVMember2022-06-30
0001270436cohn:USInsuranceJVMember2021-12-31
0001270436cohn:InsuranceSPACIIIMember2021-12-31
0001270436cohn:SPACFundsMember2022-06-30
0001270436cohn:SPACFundsMember2021-12-31
0001270436cohn:EmployeesOtherMember2022-06-30
0001270436cohn:EmployeesOtherMember2021-12-31
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission File Number: 001-32026
COHEN & COMPANY INC.
(Exact name of registrant as specified in its charter)
Maryland
|
16-1685692
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
Cira Centre
2929 Arch Street, Suite 1703
Philadelphia, Pennsylvania
|
19104
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(215) 701-9555
Not applicable
(Former name, former address and former fiscal year, if changed
since last report)
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing
requirements for the past
90 days. ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be
submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for
such shorter period that the registrant was required to submit such
files). ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company”, and “emerging growth company” in Rule
12b-2 of the Exchange Act.
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☒
|
|
|
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Indicate by check mark whether the Registrant is a shell company
(as defined by Rule 12b-2 of the Exchange
Act). ☐ Yes ☒ No
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
|
COHN
|
|
The NYSE American Stock Exchange
|
As of August 1,
2022, there were 1,716,942 shares of
common stock ($0.01 par value per share) of Cohen & Company,
Inc. ("Common Stock") outstanding.
Cohen
& Company Inc.
FORM 10-Q
INDEX TO QUARTERLY REPORT ON FORM 10-Q
June 30, 2022
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995, Section 27A of the Securities Act of 1933,
as amended or the Securities Act, and Section 21E of the
Securities Exchange Act of 1934, as amended, or the Exchange Act.
Forward-looking statements discuss matters that are not historical
facts. Because they discuss future events or conditions,
forward-looking statements may include words such as “anticipate,”
“believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,”
“seek,” “plan,” “might,” “will,” “expect,” “predict,” “project,”
“forecast,” “potential,” “continue,” negatives thereof or similar
expressions. Forward-looking statements speak only as of the date
they are made, are based on various underlying assumptions and
current expectations about the future and are not guarantees. Such
statements involve known and unknown risks, uncertainties, and
other factors that may cause our actual results, level of activity,
performance, or achievement to be materially different from the
results of operations or plans expressed or implied by such
forward-looking statements.
These forward-looking statements are found at various places
throughout this Quarterly Report on Form 10-Q and include
information concerning possible or assumed future results of our
operations, including statements about the following subjects:
|
● |
integration of operations;
|
|
● |
business strategies;
|
|
● |
growth opportunities;
|
|
● |
competitive position;
|
|
● |
market outlook;
|
|
● |
expected financial position;
|
|
● |
expected results of operations;
|
|
● |
future cash flows;
|
|
● |
financing plans;
|
|
● |
plans and objectives of management;
|
|
● |
tax treatment of the business combinations;
|
|
● |
the
special purpose acquisition companies (SPACs) of which we are
a sponsor including, INSU Acquisition III, a blank check company
that will seek to effect a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business
combination with one or more businesses;
|
|
● |
our investments in both SPACs and SPAC sponsor entities, including
through our SPAC Fund and SPAC Series Funds
|
|
● |
our
role as asset manager and sponsor in our SPAC franchise
|
|
● |
fair
value of assets; and
|
|
● |
any other statements regarding future growth, future cash needs,
future operations, business plans, future financial results, and
any other statements that are not historical facts.
|
These forward-looking statements represent our intentions, plans,
expectations, assumptions, and beliefs about future events and are
subject to risks, uncertainties, and other factors. Many of those
factors are outside of our control and could cause actual results
to differ materially from the results expressed or implied by those
forward-looking statements. In light of these risks, uncertainties,
and assumptions, the events described in the forward-looking
statements might not occur or might occur to a different extent or
at a different time than we have described. You should consider the
areas of risk and uncertainty described above and discussed under
“Item 1A — Risk Factors” included in the Company’s Annual
Report on Form 10-K for the year ended December 31, 2021. Actual
results may differ materially because of various factors, some of
which are outside our control, including the following:
|
● |
a decline in general economic conditions or the global financial
markets;
|
|
● |
continuation of the COVID-19 pandemic or future outbreaks of
COVID-19, the timing and effectiveness of vaccine distribution, and
uncertainty surrounding the length and severity of future impacts
on the global economy and on our business, liquidity, results of
operations and financial condition;
|
|
● |
economic
uncertainty and capital markets disruption which have been
significantly impacted by geopolitical instability due to the
ongoing military conflict between Russia and Ukraine; |
|
● |
risks
and liabilities due to our investments in the equity interests of
SPACs and SPAC sponsor entities including the risk of increased
regulation applicable to SPACs, risks regarding litigation in
connection with the SPACs in which we invest and those which we
sponsor, uncertainty of whether the SPACs in which we invest and
those we sponsor will consummate a business combination, adverse
impacts of COVID-19 on our SPAC franchise, significant competition
for business opportunities in the SPAC industry, write-downs or
write-offs with respect to the securities which we hold subsequent
to the consummation of an initial business combination by the SPACs
in which we invest and those which we sponsor, and the target of a
SPAC being an early-stage and financially unstable company;
|
|
● |
losses caused by financial or other problems experienced by third
parties;
|
|
● |
losses due to unidentified or unanticipated risks;
|
|
● |
losses (whether realized or unrealized) on our principal
investments;
|
|
● |
a lack of liquidity, i.e., ready access to funds for use in our
businesses; or the availability of financing at
prohibitive rates;
|
|
● |
the ability to attract and retain personnel;
|
|
● |
the ability to meet regulatory capital requirements administered by
federal agencies;
|
|
● |
the
ability to pay dividends; |
|
● |
an inability to generate incremental income from acquired, newly
established or expanded businesses;
|
|
● |
unanticipated market closures due to inclement weather or other
disasters;
|
|
● |
the volume of trading in securities including collateralized
securities transactions;
|
|
● |
the liquidity in capital markets;
|
|
● |
the creditworthiness of our correspondents, trading counterparties,
and banking and margin customers;
|
|
● |
changing interest rates and their impacts on U.S. residential
mortgage volumes;
|
|
● |
competitive conditions in each of our business segments;
|
|
● |
the availability of borrowings under credit lines, credit
agreements, warehouse agreements, and our credit facilities;
|
|
● |
the
ability of the Company to collect its outstanding reverse repo
balance from First Guaranty Mortgage Corporation; |
|
● |
the potential misconduct or errors by our employees or by entities
with whom we conduct business; and
|
|
● |
the potential for litigation and other regulatory liability.
|
Our Internet website is www.cohenandcompany.com and we make
available on our website: our filings with the Securities and
Exchange Commission (“SEC”), including annual reports, quarterly
reports, current reports and any amendments to those filings. The
reference to our website address does not constitute incorporation
by reference of the information contained therein into this Form
10-Q. We also use our website to disseminate other material
information to our investors (on the Home Page and in the “Investor
Relations” section). Among other things, we post on our website our
press releases and information about our public conference calls
(including the scheduled dates, times and the methods by which
investors and others can listen to those calls), and we make
available for replay webcasts of those calls and other
presentations for a limited time.
You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
Quarterly Report on Form 10-Q. All subsequent written and oral
forward-looking statements concerning other matters addressed in
this Quarterly Report on Form 10-Q and attributable to us or any
person acting on our behalf are expressly qualified in their
entirety by the cautionary statements contained or referred to in
this Quarterly Report on Form 10-Q. Except to the extent required
by law, we undertake no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, a change in events, conditions, circumstances, or
assumptions underlying such statements, or otherwise.
Certain Terms Used in this Quarterly Report on Form
10-Q
In this Quarterly Report on Form 10-Q, unless otherwise noted or as
the context otherwise requires, the “Company,” “we,” “us,”
and “our” refer to Cohen & Company Inc. (formerly
Institutional Financial Markets, Inc.), a Maryland corporation, and
its subsidiaries on a consolidated basis; and “Cohen &
Company, LLC” (formerly IFMI, LLC) or the “Operating
LLC” refer to the main operating subsidiary of the
Company.
“JVB Holdings” refers to JVB Financial Holdings, L.P., a
wholly owned subsidiary of the Operating LLC; “JVB” refers
to J.V.B. Financial Group, LLC, a wholly owned broker-dealer
subsidiary of JVB Holdings; "CCFESA" refers to Cohen &
Company Financial Europe Limited S.A., a majority owned subsidiary
regulated by the Autorite de Controle Prudentiel et de Resolution
("ACPR") in France; “CCFEL” refers to Cohen &
Company Financial (Europe) Limited, a wholly owned subsidiary of
the Operating LLC formerly regulated by the Central Bank of Ireland
( the “CBI”).
“Securities Act” refers to the Securities Act of 1933, as
amended; and “Exchange Act” refers to the Securities
Exchange Act of 1934, as amended.
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL
STATEMENTS.
COHEN & COMPANY
INC.
CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)
|
|
June 30, 2022
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
December 31, 2021
|
|
Assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
50,068 |
|
|
$ |
50,567 |
|
Receivables from brokers, dealers, and clearing agencies
|
|
|
141,798 |
|
|
|
68,392 |
|
Due from related parties
|
|
|
1,834 |
|
|
|
4,581 |
|
Other receivables
|
|
|
6,643 |
|
|
|
3,203 |
|
Investments-trading
|
|
|
201,924 |
|
|
|
223,865 |
|
Other investments, at fair value
|
|
|
37,558 |
|
|
|
56,033 |
|
Receivables under resale agreements
|
|
|
1,792,325 |
|
|
|
3,175,645 |
|
Investments in equity method affiliates
|
|
|
14,369 |
|
|
|
48,238 |
|
Deferred income
taxes
|
|
|
10,151 |
|
|
|
11,513 |
|
Goodwill
|
|
|
109 |
|
|
|
109 |
|
Right-of-use asset - operating leases
|
|
|
10,534 |
|
|
|
10,273 |
|
Other assets
|
|
|
3,782 |
|
|
|
3,885 |
|
Total assets
|
|
$ |
2,271,095 |
|
|
$ |
3,656,304 |
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
Payables to brokers, dealers, and clearing agencies
|
|
$ |
137,877 |
|
|
$ |
160,896 |
|
Accounts payable and other liabilities
|
|
|
33,477 |
|
|
|
22,819 |
|
Accrued compensation
|
|
|
13,678 |
|
|
|
22,577 |
|
Trading securities sold, not yet purchased
|
|
|
141,549 |
|
|
|
62,512 |
|
Other investments
sold, not yet purchased
|
|
|
128 |
|
|
|
2,488 |
|
Securities sold under agreements to repurchase
|
|
|
1,790,469 |
|
|
|
3,171,415 |
|
Lease liability - operating leases
|
|
|
11,190 |
|
|
|
10,813 |
|
Redeemable financial instruments
|
|
|
7,957 |
|
|
|
7,957 |
|
Debt
|
|
|
28,737 |
|
|
|
43,394 |
|
Total liabilities
|
|
|
2,165,062 |
|
|
|
3,504,871 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (See note 21)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity:
|
|
|
|
|
|
|
|
|
Voting Non-Convertible Preferred Stock, $0.001 par value per share,
50,000,000 shares
authorized, 27,413,098
shares issued and outstanding, respectively
|
|
|
27 |
|
|
|
27 |
|
Common Stock, $0.01 par value per share,
100,000,000 shares
authorized, 1,716,942 and 1,697,443 shares issued
and outstanding, respectively, including 288,059 and 366,293 unvested or restricted
share awards, respectively
|
|
|
17 |
|
|
|
17 |
|
Additional paid-in capital
|
|
|
72,174 |
|
|
|
72,006 |
|
Accumulated other comprehensive loss
|
|
|
(972 |
) |
|
|
(905 |
) |
Accumulated deficit
|
|
|
(20,516 |
) |
|
|
(9,204 |
) |
Total stockholders' equity
|
|
|
50,730 |
|
|
|
61,941 |
|
Non-controlling interest
|
|
|
55,303 |
|
|
|
89,492 |
|
Total equity
|
|
|
106,033 |
|
|
|
151,433 |
|
Total liabilities and equity
|
|
$ |
2,271,095 |
|
|
$ |
3,656,304 |
|
(
See accompanying notes to unaudited consolidated financial
statements.
COHEN & COMPANY
INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(LOSS)
(Dollars in Thousands, except share or per share
information)
(Unaudited)
|
|
Three Months
Ended June 30,
|
|
|
Six Months
Ended June 30,
|
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net trading
|
|
$ |
10,377 |
|
|
$ |
18,399 |
|
|
$ |
22,399 |
|
|
$ |
37,582 |
|
Asset management
|
|
|
1,898 |
|
|
|
1,838 |
|
|
|
3,787 |
|
|
|
3,931 |
|
New issue and advisory
|
|
|
3,481 |
|
|
|
850 |
|
|
|
7,251 |
|
|
|
2,689 |
|
Principal transactions and other income (loss)
|
|
|
(6,602 |
) |
|
|
(11,021 |
) |
|
|
(24,965 |
) |
|
|
68,540 |
|
Total revenues
|
|
|
9,154 |
|
|
|
10,066 |
|
|
|
8,472 |
|
|
|
112,742 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation and benefits
|
|
|
12,214 |
|
|
|
14,190 |
|
|
|
26,093 |
|
|
|
40,837 |
|
Business development, occupancy, equipment
|
|
|
1,295 |
|
|
|
787 |
|
|
|
2,543 |
|
|
|
1,506 |
|
Subscriptions, clearing, and execution
|
|
|
1,972 |
|
|
|
2,374 |
|
|
|
3,913 |
|
|
|
5,164 |
|
Professional fee and other operating
|
|
|
1,692 |
|
|
|
1,701 |
|
|
|
3,688 |
|
|
|
3,695 |
|
Depreciation and amortization
|
|
|
143 |
|
|
|
87 |
|
|
|
275 |
|
|
|
168 |
|
Total operating expenses
|
|
|
17,316 |
|
|
|
19,139 |
|
|
|
36,512 |
|
|
|
51,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(8,162 |
) |
|
|
(9,073 |
) |
|
|
(28,040 |
) |
|
|
61,372 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-operating income (expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(1,106 |
) |
|
|
(1,782 |
) |
|
|
(2,457 |
) |
|
|
(3,796 |
) |
Income (loss) from equity method affiliates
|
|
|
(3,044 |
) |
|
|
5,490 |
|
|
|
(15,148 |
) |
|
|
4,655 |
|
Other non-operating income
|
|
|
- |
|
|
|
2,127 |
|
|
|
- |
|
|
|
2,127 |
|
Income (loss) before income tax expense (benefit)
|
|
|
(12,312 |
) |
|
|
(3,238 |
) |
|
|
(45,645 |
) |
|
|
64,358 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit)
|
|
|
(60 |
) |
|
|
(43 |
) |
|
|
1,773 |
|
|
|
825 |
|
Net income (loss)
|
|
|
(12,252 |
) |
|
|
(3,195 |
) |
|
|
(47,418 |
) |
|
|
63,533 |
|
Less: Net income (loss) attributable to the non-convertible
non-controlling interest of the Operating LLC
|
|
|
(4,167 |
) |
|
|
(9,039 |
) |
|
|
(18,871 |
) |
|
|
20,931 |
|
Enterprise net income (loss)
|
|
|
(8,085 |
) |
|
|
5,844 |
|
|
|
(28,547 |
) |
|
|
42,602 |
|
Less: Net income (loss) attributable to the convertible
non-controlling interest of Cohen & Company Inc.
|
|
|
(6,228 |
) |
|
|
4,119 |
|
|
|
(19,078 |
) |
|
|
31,522 |
|
Net income (loss) attributable to Cohen & Company Inc.
|
|
$ |
(1,857 |
) |
|
$ |
1,725 |
|
|
$ |
(9,469 |
) |
|
$ |
11,080 |
|
Income (loss) per share data (see note 20)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per common share-basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income (loss) per common share
|
|
$ |
(1.30 |
) |
|
$ |
1.61 |
|
|
$ |
(6.71 |
) |
|
$ |
10.52 |
|
Weighted average shares outstanding-basic
|
|
|
1,428,237 |
|
|
|
1,071,606 |
|
|
|
1,411,596 |
|
|
|
1,052,947 |
|
Income (loss) per common share-diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income (loss) per common share
|
|
$ |
(1.53 |
) |
|
$ |
1.21 |
|
|
$ |
(6.71 |
) |
|
$ |
8.12 |
|
Weighted average shares outstanding-diluted
|
|
|
5,393,642 |
|
|
|
5,198,796 |
|
|
|
1,411,596 |
|
|
|
5,126,179 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(12,252 |
) |
|
$ |
(3,195 |
) |
|
$ |
(47,418 |
) |
|
$ |
63,533 |
|
Other comprehensive income (loss) item:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments, net of tax of
$0
|
|
|
(199 |
) |
|
|
29 |
|
|
|
(265 |
) |
|
|
(202 |
) |
Other comprehensive income (loss), net of tax of $0
|
|
|
(199 |
) |
|
|
29 |
|
|
|
(265 |
) |
|
|
(202 |
) |
Comprehensive income (loss)
|
|
|
(12,451 |
) |
|
|
(3,166 |
) |
|
|
(47,683 |
) |
|
|
63,331 |
|
Less: comprehensive income (loss) attributable to the
non-controlling interest
|
|
|
(10,541 |
) |
|
|
(4,898 |
) |
|
|
(38,142 |
) |
|
|
52,314 |
|
Comprehensive income (loss) attributable to Cohen & Company
Inc.
|
|
$ |
(1,910 |
) |
|
$ |
1,732 |
|
|
$ |
(9,541 |
) |
|
$ |
11,017 |
|
See accompanying notes to unaudited consolidated financial
statements.
COHEN & COMPANY
INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Dollars in Thousands, except share or per share
information)
(Unaudited)
|
|
Cohen & Company
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June
30, 2022
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock
|
|
|
Common Stock
|
|
|
Additional Paid-In Capital |
|
|
Retained Earnings (Accumulated
Deficit)
|
|
|
Accumulated Other Comprehensive Income
(Loss)
|
|
|
Total Stockholders' Equity
|
|
|
Non-controlling Interest
|
|
|
Total Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021
|
|
$ |
27 |
|
|
$ |
17 |
|
|
$ |
72,006 |
|
|
$ |
(9,204 |
) |
|
$ |
(905 |
) |
|
$ |
61,941 |
|
|
$ |
89,492 |
|
|
$ |
151,433 |
|
Net (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(7,612 |
) |
|
|
- |
|
|
|
(7,612 |
) |
|
|
(27,554 |
) |
|
|
(35,166 |
) |
Other comprehensive (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(19 |
) |
|
|
(19 |
) |
|
|
(47 |
) |
|
|
(66 |
) |
Acquisition / (surrender) of additional units of consolidated
subsidiary, net
|
|
|
- |
|
|
|
- |
|
|
|
(292 |
) |
|
|
- |
|
|
|
4 |
|
|
|
(288 |
) |
|
|
288 |
|
|
|
- |
|
Equity-based compensation
|
|
|
- |
|
|
|
- |
|
|
|
338 |
|
|
|
- |
|
|
|
- |
|
|
|
338 |
|
|
|
766 |
|
|
|
1,104 |
|
Shares withheld for employee taxes
|
|
|
- |
|
|
|
- |
|
|
|
(72 |
) |
|
|
- |
|
|
|
- |
|
|
|
(72 |
) |
|
|
(145 |
) |
|
|
(217 |
) |
Dividends/distributions to convertible non-controlling interest
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,481 |
) |
|
|
- |
|
|
|
(1,481 |
) |
|
|
(3,475 |
) |
|
|
(4,956 |
) |
Convertible non-controlling interest investment
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
15,000 |
|
|
|
15,000 |
|
Non-convertible non-controlling interest investment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
6 |
|
|
|
6 |
|
Non-convertible non-controlling interest distributions
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(5,660 |
) |
|
|
(5,660 |
) |
March 31, 2022
|
|
$ |
27 |
|
|
$ |
17 |
|
|
$ |
71,980 |
|
|
$ |
(18,297 |
) |
|
$ |
(920 |
) |
|
$ |
52,807 |
|
|
$ |
68,671 |
|
|
$ |
121,478 |
|
Net (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,857 |
) |
|
|
- |
|
|
|
(1,857 |
) |
|
|
(10,395 |
) |
|
|
(12,252 |
) |
Other comprehensive (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(53 |
) |
|
|
(53 |
) |
|
|
(146 |
) |
|
|
(199 |
) |
Acquisition / (surrender) of additional units of consolidated
subsidiary, net
|
|
|
- |
|
|
|
- |
|
|
|
(89 |
) |
|
|
- |
|
|
|
1 |
|
|
|
(88 |
) |
|
|
88 |
|
|
|
- |
|
Equity-based compensation
|
|
|
- |
|
|
|
- |
|
|
|
287 |
|
|
|
- |
|
|
|
- |
|
|
|
287 |
|
|
|
795 |
|
|
|
1,082 |
|
Shares withheld for employee taxes
|
|
|
- |
|
|
|
- |
|
|
|
(4 |
) |
|
|
- |
|
|
|
- |
|
|
|
(4 |
) |
|
|
(13 |
) |
|
|
(17 |
) |
Dividends/distributions to convertible non-controlling interest
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(362 |
) |
|
|
- |
|
|
|
(362 |
) |
|
|
(1,060 |
) |
|
|
(1,422 |
) |
Non-convertible non-controlling interest investment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3 |
|
|
|
3 |
|
Non-convertible non-controlling interest distributions
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,640 |
) |
|
|
(2,640 |
) |
June 30, 2022
|
|
$ |
27 |
|
|
$ |
17 |
|
|
$ |
72,174 |
|
|
$ |
(20,516 |
) |
|
$ |
(972 |
) |
|
$ |
50,730 |
|
|
$ |
55,303 |
|
|
$ |
106,033 |
|
|
|
Cohen & Company
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June
30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock
|
|
|
Common Stock
|
|
|
Additional Paid-In Capital
|
|
|
Retained Earnings (Accumulated
Deficit)
|
|
|
Accumulated Other Comprehensive Income
(Loss)
|
|
|
Total Stockholders' Equity
|
|
|
Non-controlling Interest
|
|
|
Total Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020
|
|
$ |
27 |
|
|
$ |
13 |
|
|
$ |
65,031 |
|
|
$ |
(20,341 |
) |
|
$ |
(821 |
) |
|
$ |
43,909 |
|
|
$ |
57,528 |
|
|
$ |
101,437 |
|
Net income
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
9,355 |
|
|
|
- |
|
|
|
9,355 |
|
|
|
57,373 |
|
|
|
66,728 |
|
Other comprehensive loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(70 |
) |
|
|
(70 |
) |
|
|
(161 |
) |
|
|
(231 |
) |
Acquisition / (surrender) of additional units of consolidated
subsidiary, net
|
|
|
- |
|
|
|
- |
|
|
|
926 |
|
|
|
- |
|
|
|
4 |
|
|
|
930 |
|
|
|
(930 |
) |
|
|
- |
|
Equity-based compensation and vesting of shares
|
|
|
- |
|
|
|
- |
|
|
|
153 |
|
|
|
- |
|
|
|
- |
|
|
|
153 |
|
|
|
13,488 |
|
|
|
13,641 |
|
Shares withheld for employee taxes
|
|
|
- |
|
|
|
- |
|
|
|
(97 |
) |
|
|
- |
|
|
|
- |
|
|
|
(97 |
) |
|
|
(264 |
) |
|
|
(361 |
) |
Purchase and retirement of Common Stock
|
|
|
- |
|
|
|
|
|
|
|
(662 |
) |
|
|
|
|
|
|
|
|
|
|
(662 |
) |
|
|
- |
|
|
|
(662 |
) |
Dividends/distributions to convertible non-controlling interest
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(7 |
) |
|
|
- |
|
|
|
(7 |
) |
|
|
(11 |
) |
|
|
(18 |
) |
Non-convertible non-controlling interest investment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
23 |
|
|
|
23 |
|
Non-convertible non-controlling interest distributions
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(25,885 |
) |
|
|
(25,885 |
) |
March 31, 2021
|
|
$ |
27 |
|
|
$ |
13 |
|
|
$ |
65,351 |
|
|
$ |
(10,993 |
) |
|
$ |
(887 |
) |
|
$ |
53,511 |
|
|
$ |
101,161 |
|
|
$ |
154,672 |
|
Net income (loss)
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,725 |
|
|
|
- |
|
|
|
1,725 |
|
|
|
(4,920 |
) |
|
|
(3,195 |
) |
Other comprehensive income
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
7 |
|
|
|
7 |
|
|
|
22 |
|
|
|
29 |
|
Common stock issued, net
|
|
|
- |
|
|
|
1 |
|
|
|
2,672 |
|
|
|
- |
|
|
|
- |
|
|
|
2,673 |
|
|
|
- |
|
|
|
2,673 |
|
Acquisition / (surrender) of additional units of consolidated
subsidiary, net
|
|
|
- |
|
|
|
- |
|
|
|
1,449 |
|
|
|
- |
|
|
|
(18 |
) |
|
|
1,431 |
|
|
|
(1,431 |
) |
|
|
- |
|
Equity-based compensation and vesting of shares
|
|
|
- |
|
|
|
- |
|
|
|
145 |
|
|
|
- |
|
|
|
- |
|
|
|
145 |
|
|
|
382 |
|
|
|
527 |
|
Purchase and retirement of Common Stock
|
|
|
- |
|
|
|
- |
|
|
|
(7 |
) |
|
|
- |
|
|
|
- |
|
|
|
(7 |
) |
|
|
- |
|
|
|
(7 |
) |
Non-convertible non-controlling interest investment
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,506 |
|
|
|
2,506 |
|
Non-convertible non-controlling interest distributions
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(30,769 |
) |
|
|
(30,769 |
) |
June 30, 2021
|
|
$ |
27 |
|
|
$ |
14 |
|
|
$ |
69,610 |
|
|
$ |
(9,268 |
) |
|
$ |
(898 |
) |
|
$ |
59,485 |
|
|
$ |
66,951 |
|
|
$ |
126,436 |
|
See accompanying notes to unaudited consolidated financial
statements.
COHEN
& COMPANY INC.
Consolidated Statements of Cash Flows
(Dollars in Thousands)
(Unaudited)
|
|
Six Months
Ended June 30,
|
|
|
|
2022
|
|
|
2021
|
|
Operating activities
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(47,418 |
) |
|
$ |
63,533 |
|
Adjustments to reconcile net income (loss) to net cash provided by
(used in) operating activities:
|
|
|
|
|
|
|
|
|
Equity-based compensation
|
|
|
2,186 |
|
|
|
14,168 |
|
Accretion of income on other investments, at fair value
|
|
|
- |
|
|
|
- |
|
Loss (gain) on other investments, at fair value
|
|
|
25,737 |
|
|
|
(67,236 |
) |
Loss (gain) on other
investments, sold not yet purchased
|
|
|
(257 |
) |
|
|
(776 |
) |
(Income) loss from equity method affiliates
|
|
|
15,148 |
|
|
|
(4,655 |
) |
Depreciation and amortization
|
|
|
275 |
|
|
|
168 |
|
Amortization of discount on debt
|
|
|
343 |
|
|
|
419 |
|
Deferred tax provision (benefit)
|
|
|
1,362 |
|
|
|
562 |
|
Other non-operating income - forgiveness of debt
|
|
|
|
|
|
|
(2,127 |
) |
Change in operating assets and liabilities, net:
|
|
|
|
|
|
|
|
|
Change in receivables from / payables to brokers, dealers, and
clearing agencies
|
|
|
(96,425 |
) |
|
|
1,994 |
|
Change in receivables from / payables to related parties, net
|
|
|
2,747 |
|
|
|
80 |
|
(Increase) decrease in other receivables
|
|
|
(3,440 |
) |
|
|
(5,308 |
) |
(Increase) decrease in investments-trading
|
|
|
21,941 |
|
|
|
(10,858 |
) |
(Increase) decrease in receivables under resale agreement
|
|
|
1,383,320 |
|
|
|
(311,172 |
) |
(Increase) decrease in other assets
|
|
|
(40 |
) |
|
|
(6,169 |
) |
Increase (decrease) in accounts payable and other liabilities
|
|
|
10,970 |
|
|
|
(2,424 |
) |
Increase (decrease) in accrued compensation
|
|
|
(8,899 |
) |
|
|
1,671 |
|
Increase (decrease) in trading securities sold, not yet
purchased
|
|
|
79,037 |
|
|
|
(1,565 |
) |
Increase (decrease) in securities sold under agreement to
repurchase
|
|
|
(1,380,946 |
) |
|
|
305,972 |
|
Net cash provided by (used in) operating activities
|
|
|
5,641 |
|
|
|
(23,723 |
) |
Investing activities
|
|
|
|
|
|
|
|
|
Purchase of other investments, at fair value
|
|
|
(4,792 |
) |
|
|
(49,713 |
) |
Purchase of
investments - other investments sold, not yet purchased, at fair
value
|
|
|
(4,791 |
) |
|
|
(16,415 |
) |
Sales and returns of principal-other investments, at fair value
|
|
|
11,306 |
|
|
|
56,335 |
|
Sales and returns of
principal - other investments sold, not yet purchased, at fair
value
|
|
|
1,851 |
|
|
|
21,344 |
|
Investment in equity method affiliate
|
|
|
(620 |
) |
|
|
(1,027 |
) |
Distribution from equity method affiliate
|
|
|
65 |
|
|
|
50 |
|
Purchase of furniture, equipment, and leasehold improvements
|
|
|
(393 |
) |
|
|
(319 |
) |
Net cash provided by (used in) investing activities
|
|
|
2,626 |
|
|
|
10,255 |
|
Financing activities
|
|
|
|
|
|
|
|
|
Proceeds from debt
|
|
|
2,250 |
|
|
|
- |
|
Repayment of debt
|
|
|
(2,250 |
) |
|
|
- |
|
Repayments of redeemable financial instruments
|
|
|
- |
|
|
|
(4,000 |
) |
Cash used to net share settle equity awards
|
|
|
(234 |
) |
|
|
(361 |
) |
Proceeds from issuance of Common Stock
|
|
|
- |
|
|
|
2,673 |
|
Purchase and
retirement of Common Stock
|
|
|
- |
|
|
|
(669 |
) |
Cohen & Company Inc. dividends
|
|
|
(1,843 |
) |
|
|
(7 |
) |
Convertible
non-controlling interest distributions
|
|
|
(4,535 |
) |
|
|
(137 |
) |
Non-convertible
non-controlling interest investment
|
|
|
9 |
|
|
|
2,529 |
|
Non-convertible non-controlling interest distributions
|
|
|
(1,883 |
) |
|
|
- |
|
Net cash provided by
(used in) financing activities
|
|
|
(8,486 |
) |
|
|
28 |
|
Effect of exchange rate on cash
|
|
|
(280 |
) |
|
|
(153 |
) |
Net increase
(decrease) in cash and cash equivalents
|
|
|
(499 |
) |
|
|
(13,593 |
) |
Cash and cash equivalents, beginning of period
|
|
|
50,567 |
|
|
|
41,996 |
|
Cash and cash
equivalents, end of period
|
|
$ |
50,068 |
|
|
$ |
28,403 |
|
See accompanying notes to unaudited consolidated financial
statements.
COHEN & COMPANY INC.
Notes to Consolidated Financial Statements
(Dollars in Thousands, except share and per share
information)
(Unaudited)
1. ORGANIZATION AND NATURE OF
OPERATIONS
Organizational History
Cohen Brothers, LLC (“Cohen Brothers”) was formed on October 7, 2004 by
Cohen Bros. Financial, LLC (“CBF”). Cohen Brothers was established
to acquire the net assets of CBF’s subsidiaries (the “Formation
Transaction”): Cohen Bros. & Company, Inc.; Cohen Frères
SAS; Dekania Investors, LLC; Emporia Capital Management, LLC; and
the majority interest in Cohen Bros. & Toroian Investment
Management, Inc. The Formation Transaction was accomplished through
a series of transactions occurring between March 4,
2005 and May 31,
2005.
From its formation until December 16, 2009,
Cohen Brothers operated as a privately owned limited liability
company. On December 16,
2009, Cohen Brothers completed its
merger (the “AFN Merger”) with a subsidiary of Alesco Financial
Inc. (“AFN”), a publicly traded real estate investment trust.
As a result of the AFN Merger, AFN contributed substantially all of
its assets into Cohen Brothers in exchange for newly issued units
of membership interests directly from Cohen Brothers. In addition,
AFN received additional Cohen Brothers membership interests
directly from its members in exchange for AFN common stock. In
accordance with accounting principles generally accepted in the
United States of America (“U.S. GAAP”), the AFN Merger was
accounted for as a reverse acquisition, and Cohen Brothers was
deemed to be the accounting acquirer. As a result, all of AFN’s
assets and liabilities were required to be revalued at fair value
as of the acquisition date. The remaining units of membership
interests of Cohen Brothers that were not held by AFN were included as a component
of non-controlling interest in the consolidated balance sheets.
Subsequent to the AFN Merger, AFN was renamed Cohen &
Company Inc. In January 2011, it
was renamed again as Institutional Financial Markets, Inc. (“IFMI”)
and on September 1, 2017 it was
renamed again as Cohen & Company Inc. Effective
January 1, 2010, the
Company ceased to qualify as a REIT.
The Company
The Company is a financial services company specializing in fixed
income and SPAC markets. As of June 30,
2022, the
Company had
$2.21 billion in assets under management (“AUM”) of which
52.8% or $1.17 billion, was in collateralized debt
obligations (“CDOs”). The remaining portion of AUM is from a
diversified mix of Investment Vehicles (as defined herein).
In these financial statements, the “Company” refers to Cohen &
Company Inc. and its subsidiaries on a consolidated basis. Cohen
& Company, LLC or the “Operating LLC” refers to the main
operating subsidiary of the Company. “Cohen Brothers” refers
to the pre-AFN Merger Cohen Brothers, LLC and its subsidiaries.
“AFN” refers to the pre-merger Alesco Financial Inc. and its
subsidiaries. When the term “Cohen & Company Inc.” is used, it
is referring to the parent company itself. “JVB Holdings” refers to
J.V.B. Financial Holdings, LP; “JVB” refers to J.V.B. Financial
Group LLC, a broker-dealer subsidiary; "CCFESA" refers to Cohen
& Company Financial Europe Limited S.A., a majority owned
subsidiary regulated by the Autorite de Controle Prudentiel et de
Resolution ("ACPR") in
France. “CCFL” refers to Cohen & Company Financial Limited
(formerly known as EuroDekania Management LTD), a subsidiary
formerly regulated by the Financial Conduct Authority (formerly
known as Financial Services Authority) in the United Kingdom;
“CCFEL” refers to Cohen & Company Financial (Europe) Limited, a
subsidiary formerly regulated by the Central Bank of Ireland in
Ireland.
The Company’s business is organized into the following three business segments.
Capital Markets:
The Company’s Capital Markets business segment consists primarily
of fixed income sales, trading, matched book repurchase agreement
(“repo”) financing, new issue placements in corporate and
securitized products, and advisory services. The Company’s fixed
income sales and trading group provides trade execution to
corporate investors, institutional investors, mortgage originators,
and other smaller broker-dealers. The Company specializes in a
variety of products, including but not limited to: corporate bonds, asset backed
securities (“ABS”), mortgage-backed securities (“MBS”), residential
mortgage-backed securities (“RMBS”), CDOs, collateralized loan
obligations (“CLOs”), collateralized bond obligations (“CBOs”),
collateralized mortgage obligations (“CMOs”), municipal securities,
to-be-announced securities (“TBAs”) and other forward agency MBS
contracts, U.S. government bonds, U.S. government agency
securities, brokered deposits and certificates of deposit (“CDs”)
for small banks, and hybrid capital of financial institutions
including trust preferred securities (“TruPS”), whole loans,
residential transition loans, (“RTLs”), and other structured
financial instruments. The Company also offers execution and
brokerage services for equity products. The Company operates its
capital markets activities primarily through its subsidiaries: JVB
in the United States, and CCFESA in Europe. A division
of JVB, Cohen & Company Capital Markets is the
Company's full-service boutique investment banking platform
focusing on SPAC advisory, capital markets advisory, and M&A
advisory, with clients primarily in the financial technology
(commonly referred to as "fintech") and SPAC
spaces.
Asset Management:
The Company’s Asset Management business segment manages assets
within CDOs, managed accounts, joint ventures, and investment funds
(collectively referred to as “Investment Vehicles”). A CDO is a
form of secured borrowing. The borrowing is secured by different
types of fixed income assets such as corporate or mortgage loans or
bonds. The borrowing is in the form of a securitization, which
means that the lenders are actually investing in notes backed by
the assets. In the event of default, the lenders will have recourse
only to the assets securing the loan. The Company’s Asset
Management business segment includes its fee-based asset management
operations, which include ongoing base and incentive management
fees.
Principal
Investing: The Company’s Principal Investing business
segment is comprised of investments that the Company holds related
to its SPAC franchise and other investments the Company has made
for the purpose of earning an investment return rather than
investments made to support the Company’s trading, matched book
repo, or other Capital Markets business segment
activities. These investments are included in the
Company’s other investments, at fair value; other investments sold,
not yet purchased; and
investments in equity method affiliates in the Company’s
consolidated balance sheets.
The Company generates its revenue by business segment primarily
through the following activities.
Capital
Markets
|
●
|
Trading activities of the Company, which include execution and
brokerage services, riskless trading activities as well as gains
and losses (unrealized and realized) and income and expense earned
on securities and derivatives classified as trading;
|
|
●
|
Net interest income on the Company’s matched book repo financing
activities; and
|
|
●
|
New issue and advisory revenue comprised primarily of (i) new
issue revenue associated with originating, arranging, or placing
newly created financial instruments and (ii) revenue from
advisory services.
|
Asset
Management
|
●
|
Asset management fees for the Company’s on-going asset management
services provided to certain Investment Vehicles, which may include fees both senior and subordinate
to the securities in the Investment Vehicle, and incentive
management fees earned based on the performance of the various
Investment Vehicles.
|
Principal
Investing
|
●
|
Gains and losses (unrealized and realized) and income and expense
earned on securities classified as other investments at fair value
and other investments sold, not yet
purchased; and
|
|
●
|
Income
and loss earned on equity method investments. |
2. BASIS OF PRESENTATION
The financial statements of the Company included herein were
prepared in conformity with U.S. GAAP for interim financial
information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by U.S. GAAP for complete financial statements.
The information furnished includes all adjustments and accruals of
a normal recurring nature, which, in the opinion of management, are
necessary for a fair presentation of results for the interim month
periods. All intercompany accounts and transactions have been
eliminated in consolidation. The results for the six months ended June 30, 2022 and 2021 are not
necessarily indicative of the results for the entire year or any
subsequent interim period. These financial statements should be
read in conjunction with the audited consolidated financial
statements and notes thereto included in the Company’s Annual
Report on Form 10-K for the year
ended December 31,
2021.
Capitalized terms used
herein without definition have the meanings ascribed to them in the
Annual Report on Form 10-K for the
year ended December 31,
2021.
CORRECTION OF AN IMMATERIAL ERROR IN PREVIOUSLY ISSUED FINANCIAL
STATEMENTS
During the three months ended March 31, 2022, the Company determined that
it had made an error when calculating its December 31, 2021, deferred tax asset and
current tax payable related to its net operating loss
carryforwards in certain local jurisdictions. Accordingly,
the Company recorded an adjustment in that period and revised the
December 31, 2021 balances
presented herein. The below table shows the line items
impacted and compares the amounts as previously stated to the
revised amounts included in this report.
The balance sheet amounts
shown below are as of December 31,
2021. The income statement amounts are for the year
ended December 31,
2021.
Balance Sheet
|
|
|
As Stated |
|
|
|
Revised |
|
|
|
Change |
|
Deferred income taxes
|
|
$ |
9,468 |
|
|
$ |
11,513 |
|
|
$ |
2,045 |
|
Accounts payable and other liabilities
|
|
|
22,701 |
|
|
|
22,819 |
|
|
|
118 |
|
Accumulated deficit
|
|
|
(9,730 |
) |
|
|
(9,204 |
) |
|
|
526 |
|
Non-controlling interest
|
|
$ |
88,091 |
|
|
$ |
89,492 |
|
|
$ |
1,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Statement
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
(benefit)
|
|
$ |
(1,614 |
) |
|
$ |
(3,541 |
) |
|
$ |
(1,927 |
) |
Net Income
(loss)
|
|
|
72,111 |
|
|
|
74,038 |
|
|
|
1,927 |
|
Net Income
attributable to non-controlling interests
|
|
|
60,829 |
|
|
|
62,230 |
|
|
|
1,401 |
|
Net income (loss)
attributable to Cohen & Company, Inc.
|
|
$ |
11,282 |
|
|
$ |
11,808 |
|
|
$ |
526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic Earnings Per
Share
|
|
$ |
9.50 |
|
|
$ |
9.95 |
|
|
$ |
0.45 |
|
Diluted Earnings Per
Share
|
|
$ |
7.48 |
|
|
$ |
7.83 |
|
|
$ |
0.35 |
|
3. SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
A. Adoption of New Accounting Standards
In December 2019, the FASB issued
ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting
for Income Taxes. This ASU is intended to simplify accounting
for income taxes. It removes specific exceptions to the general
principles in Topic 740 and amends
existing guidance to improve consistent application. The
Company’s adoption of the provisions of ASU 2019-12,
effective January 1, 2021, did
not have an effect on the Company’s
consolidated financial statements.
In January 2020, the FASB issued
ASU 2020-01, Investments—Equity Securities (Topic
321), Investments—Equity Method and
Joint Ventures (Topic 323), and
Derivatives and Hedging (Topic 815)—Clarifying the Interactions between
Topic 321, Topic 323, and Topic 815. This ASU clarifies certain
accounting topics impacted by Topic 321 Investments-Equity Securities. These
topics include measuring equity securities using the measurement
alternative, how the measurement alternative should be applied to
equity method accounting, and certain forward contracts and
purchased options which would be accounted for under the equity
method of accounting upon settlement or exercise. The Company’s
adoption of the provisions of ASU 2020-01,
effective January 1, 2021, did
not have an effect on the Company’s
consolidated financial statements.
In March 2020, the FASB issued ASU
2020-04, Reference Rate Reform (Topic
848): Facilitation of the Effects
of Reference Rate Reform on Financial Reporting. Certain
aspects of this topic were later enhanced and clarified in
January 2021 when the FASB issued
ASU 2021-01 Reference Rate Reform (Topic 848). These ASUs provides temporary
optional guidance to ease the burden in accounting for reference
rate reform by providing optional expedients and exceptions for
applying generally accepted accounting principles to contract
modifications and hedging relationships, subject to meeting certain
criteria, that reference LIBOR or another reference rate expected
to be discontinued. The ASU is intended to help stakeholders
during the global market-wide reference rate transition period and
will be in effect for a limited time through December 31, 2022. The Company’s
adoption of the provisions of ASU 2020-04 and
ASU 2021-01, effective March 12, 2020, did not have an effect on the Company’s
consolidated financial statements.
In October 2020, the FASB issued ASU 2020-08,
Codification Improvements to Subtopic 310-20,
Receivables—Nonrefundable Fees and Other Costs.
The ASU clarifies that an entity should reevaluate
whether a callable debt security is within the scope of ASC
paragraph 310-20-35-33 for
each reporting period. The Company’s adoption of the
provisions of ASU 2020-08, effective January 1, 2022, did not have an effect on the Company’s
consolidated financial statements.
In October 2020, the FASB issued
2020-10, Codification
Improvements. The ASU affects a wide variety of
Topics in the Codification. The ASU, among other things,
contains amendments that improve consistency of the
Codification by including all disclosure guidance in the
appropriate Disclosure Section. Many of the amendments arose
because the FASB provided an option to give certain information
either on the face of the financial statements or in the notes to
financial statements and that option only was included in the Other
Presentation Matters Section of the Codification. The option
to disclose information in the notes to financial statements should
have been codified in the Disclosure Section as well as the Other
Presentation Matters Section (or other Section of the Codification
in which the option to disclose in the notes to financial
statements appears). The Company’s adoption of the provisions of
ASU 2020-10, effective January 1, 2022, did not have an effect on the Company’s
consolidated financial statements.
In May 2021, the FASB issued
2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments
(Subtopic 470-50), Compensation (Topic 718), and Derivatives and Hedging—Contracts
in Entity's Own Equity (Subtopic 815-40): Issuer's Accounting for Certain
Modifications or Exchanges of Freestanding Equity-Classified
Written Call Options. This ASU provides guidance for a
modification or an exchange of a freestanding equity-classified
written call option that is not
within the scope of another topic. It specifically addresses:
(1) how an entity should treat a
modification of the terms or conditions or an exchange of a
freestanding equity-classified written call option that remains
equity classified after modification or exchange; (2) how an entity should measure the effect of
a modification or an exchange of a freestanding equity-classified
written call option that remains equity classified after
modification or exchange; and (3)
how an entity should recognize the effect of a modification or an
exchange of a freestanding equity-classified written call option
that remains equity classified after modification or
exchange. The Company’s adoption of the provisions of ASU
2021-04, effective January 1, 2022, did not have an effect on the Company’s
consolidated financial statements.
In October 2021, the FASB issued
ASU 2021-08, Business Combinations (Topic
805): Accounting for Contract
Assets and Contract Liabilities from Contracts with
Customers. This ASU requires entities to apply Topic
606 to recognize and measure
contract assets and contract liabilities in a business combination.
The amendments improve comparability after the business combination
by providing consistent recognition and measurement guidance for
revenue contracts with customers acquired in a business combination
and revenue contracts with customers not acquired in a business
combination. The Company’s adoption of the provisions of ASU
2021-08, effective January 1, 2022, did not have an effect on the Company’s
consolidated financial statements.
In October 2021, the FASB issued
ASU 2021-10, Government Assistance (Topic
832): Disclosures by Business
Entities about Government Assistance. This ASU includes
amendments that are expected to increase transparency in
financial reporting by requiring business entities to disclose
information about certain types of government assistance they
receive. The amendments require the following annual
disclosures about transactions with a government that are accounted
for by applying a grant or contribution accounting model by analogy
to other accounting guidance: (i) information about the
nature of the transactions and the related accounting policy used
to account for the transactions; (ii) the line items on the balance
sheet and income statement that are affected by the transactions,
and the amounts applicable to each financial statement line item;
and (iii) significant terms and conditions of the transactions,
including commitments and contingencies. The Company’s
adoption of the provisions of ASU 2021-10,
effective January 1, 2022, did
not have an effect on the Company’s
consolidated financial statements.
B. Recent Accounting Developments
In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and
Other Options (Subtopic 470-20) and
Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic
815-40): Accounting for Convertible
Instruments and Contracts in an Entity's Own Equity. This
ASU simplifies accounting for convertible instruments by removing
major separation models currently required. The ASU
removes certain settlement conditions that are required for equity
contracts to qualify for the derivative scope exception. The
ASU also simplifies the diluted earnings per share (EPS)
calculation in certain areas. This ASU is
effective for fiscal years beginning after December 15, 2023, including interim periods
within those fiscal years. The Company is currently
evaluating the new guidance to determine the impact it may have on its consolidated financial
statements.
In March 2022, the FASB issued ASU 2022-02, Financial Instruments—Credit
Losses (Topic 326): Troubled Debt
Restructurings ("TDRs") and Vintage Disclosures. The
amendments in this ASU eliminate TDR recognition and measurement
guidance and instead, require that an entity evaluate (consistent
with the accounting for other loan modifications) whether the
modification represents a new loan or a continuation of an existing
loan. The amendments also enhance existing disclosure
requirements and introduce new requirements related to certain
modifications of receivables made to borrowers experiencing
financial difficulty. This ASU is
effective for fiscal years beginning after December 15, 2022, including interim periods
within those fiscal years. The Company is currently
evaluating the new guidance to determine the impact it may have on its consolidated financial
statements.
In June 2022, the FASB
issued ASU 2022-03, Fair
Value Measurement (Topic 820): Fair Value Measurement of Equity
Securities Subject to Contractual Sale Restrictions.
The amendments clarify that a contractual restriction on the
sale of an equity security is not
considered part of the unit of account of the equity security and,
therefore, is not considered in
measuring fair value. This ASU is effective for fiscal years
beginning after December 15,
2023. Early adoption is permitted. The
Company is currently evaluating the new guidance to determine the
impact it may have on its
consolidated financial statements.
C. Fair Value of Financial Instruments
The following methods and assumptions were used by the Company in
estimating the fair value of its financial instruments. These
determinations were based on available market information and
appropriate valuation methodologies. Considerable judgment is
required to interpret market data to develop the estimates and,
therefore, these estimates may
not necessarily be indicative of
the amount the Company could realize in a current market exchange.
The use of different market assumptions and/or estimation
methodologies may have a material
effect on the estimated fair value amounts. Refer to note
8 for a discussion of the valuation
hierarchy with respect to investments-trading; other investments,
at fair value; other investments sold, not yet purchased; and derivatives held by
the Company.
Cash and cash
equivalents: Cash and cash equivalents are carried at
historical cost, which is assumed to approximate fair value. The
estimated fair value measurement of cash and cash equivalents is
classified within level 1 of the
valuation hierarchy.
Investments-trading: These
amounts are carried at fair value. The fair value is based on
either quoted market prices of an active exchange, independent
broker market quotations, market price quotations from third- party pricing services, or valuation
models when quotations are not
available.
Other investments, at
fair value: These amounts are carried at fair value. The
fair value is based on quoted market prices of an active exchange,
independent broker market quotations, or valuation models when
quotations are not available.
In the case of investments in alternative investment funds, fair
value is generally based on the reported net asset value of the
underlying fund.
Other investments sold,
not yet
purchased: These amounts are carried at fair
value. The fair value is based on quoted market prices of an active
exchange, independent broker market quotations, or valuation models
when quotations are not
available.
Receivables under resale
agreements: Receivables under resale agreements are carried
at their contracted resale price, have short-term maturities, and
are repriced frequently or bear market interest rates and,
accordingly, these contracts are at amounts that approximate fair
value. The estimated fair value measurements of receivables under
resale agreements are based on observations of actual market
activity and are generally classified within level 2 of the valuation hierarchy.
Trading securities sold,
not yet purchased: These
amounts are carried at fair value. The fair value is based on
quoted market prices of an active exchange, independent market
quotations, market price quotations from third party pricing services, or valuation
models when quotations are not
available.
Securities sold under
agreements to repurchase: The liabilities for securities
sold under agreements to repurchase are carried at their contracted
repurchase price, have short-term maturities, and are repriced
frequently or bear market interest rates and accordingly,
these contracts are carried at amounts that approximate fair value.
The estimated fair value measurements of securities sold under
agreements to repurchase are based on observations of actual market
activity and are generally classified within level 2 of the valuation hierarchy.
Redeemable financial
instruments: The liabilities for redeemable financial
instruments are carried at their redemption value, which
approximates fair value. The estimated fair value measurement of
the redeemable financial instruments is classified within level
3 of the valuation
hierarchy.
Debt: These
amounts are carried at outstanding principal less unamortized
discount and deferred financing costs. However, a substantial
portion of the debt was assumed in the AFN Merger and recorded at
fair value as of that date. As of June
30, 2022 and December 31,
2021, the fair value of the Company’s debt was
estimated to be $31,958 and $54,284,
respectively. The estimated fair value measurements of
the debt are generally based on discounted cash flow models
prepared by the Company’s management primarily using discount rates
for similar instruments issued to companies with similar credit
risks to the Company and are generally classified within level
3 of the value hierarchy.
Derivatives: These
amounts are carried at fair value. Derivatives may be included as a component of
investments-trading; trading securities sold, not yet purchased; other investments, at fair
value; and other investments, sold not yet purchased. The fair value is
generally based on quoted market prices on an exchange that is
deemed to be active for derivative instruments such as foreign
currency forward contracts and Eurodollar futures. For
derivative instruments, such as TBAs and other extended settlement
trades, the fair value is generally based on market price
quotations from third party pricing
services.
4. OTHER RECENT BUSINESS
TRANSACTIONS OR EVENTS
Conversion of the 2017
Convertible Note
On March 10, 2017, the Operating
LLC issued to DGC Family Fintech Trust (the “DGC Trust”), a
trust established by Daniel G. Cohen, a convertible senior secured
promissory note in the aggregate principal amount of $15,000 (the
"2017 Convertible Note"). On
March 20, 2022, the DGC Trust
elected to convert the 2017
Convertible Note into an aggregate of 10,344,827 units of
membership interests in the Operating LLC at the conversion rate
specified in the 2017 Convertible
Note agreement of $1.45 per unit. As a result of such
conversion, the 2017 Convertible
Note was cancelled in its entirety. These units of
membership interests have the same conversion and redemption rights
as the existing convertible non-controlling interest units of
membership interests. See note 21 to the Company's December 31, 2021 Annual Report filed on Form
10-K for additional information
regarding the 2017 Convertible
Note.
Pursuant to the DGC Trust’s governing documents, Daniel G. Cohen
has the ability to acquire at any time any of the DGC Trust’s
assets, including the units of membership interest, by substituting
other property of an equivalent value without the approval or
consent of any person, including any trustee or beneficiary of the
DGC Trust. See Notes 16 and
24.
The 2020 Senior
Notes
On January 31, 2022, the Operating
LLC and JKD Investor entered into a Note Purchase Agreement.
On January 31, 2020, the
Operating LLC entered into a Note Purchase Agreement (the “Original
Purchase Agreement”) with JKD Capital Partners I LTD, a New
York corporation (“JKD Investor”), and RN Capital Solutions LLC, a
Delaware limited liability company (“RNCS”). The JKD Investor
is owned by Jack DiMaio, Jr., the vice chairman of the Company’s
board of directors and the Operating LLC’s board of managers, and
his spouse. The note purchased by the JKD Investor is herein
referred to as the “JKD Note.”
Pursuant to the Original Purchase Agreement, JKD Investor and
RNCS each purchased a senior promissory note in the principal
amount of $2,250 (for an aggregate investment of
$4,500). The senior promissory notes bore interest at a
fixed rate of 12% per annum
and matured on January 31,
2022, pursuant to which, among other things, on such date, (i)
JKD Investor paid to the Operating LLC an additional
$2,250 and (ii) in consideration for such funds, the Operating
LLC issued to JKD Investor an Amended and Restated Senior
Promissory Note in the aggregate principal amount of
$4,500 (the “Amended and Restated Note”), which Amended and
Restated Note amended and restated the JKD Note in its
entirety. The 2022 Purchase
Agreement contains customary representations and warranties on the
part of each of JKD Investor and the Operating LLC. The
Company used these proceeds to retire $2,250 of existing 2020 Senior Notes held by RNCS. See
note 16 and 24.
New Commercial Real Estate Opportunities
(“CREO”) JV
On September 3, 2021, the Company
committed to invest up to $15,000 of equity in a newly formed joint
venture (the “CREO JV”) with an outside investor who committed to
invest approximately $435,000 of equity in the CREO
JV. The Company is required to invest 7.5% of the total
equity of the CREO JV with an absolute limit of
$15,000. The CREO JV is managed by the Company.
The CREO JV was formed for the purposes of investing
in primarily multi-family commercial real estate mortgage-backed
loans and below-investment-grade rated tranches in CRE CLOs
collateralized by mostly transitional commercial real estate
mortgage-backed loans. “CRE CLO” means any pooling of commercial
real estate mortgage-backed loans into a collateralized loan
obligation.
The commercial real estate loans that will
be funded by the CREO JV may be originated by the Company
and the Company may earn
origination fees in connection with such transactions. In addition,
the Company may earn structuring
fees in connection with structuring and consummating a CRE CLO
consisting of a pooling of commercial real estate loans. The
Company also may
earn management fees as manager of any CRE CLOs based on
the value of the assets consolidated into a CRE CLO (calculated in
accordance with the terms of such CRE CLO), payable from the
proceeds generated by and in accordance with the distribution
waterfall of such CRE CLO.
The Company has elected the fair value option in accordance
with the provisions of FASB ASC 820, Fair Value
Measurements (“FASB ASC 820”) to account for its investment in
the CREO JV. The investment is included in other
investments at fair value, on the consolidated balance sheet and
gains and losses (both realized and unrealized) are recognized
in the consolidated statement of operations as a
component of principal transactions and other
income. Because the CREO JV has the attributes
of investment companies as described in FASB ASC 946-15-2, the
Company estimates the fair value of its investment using the
net asset value (“NAV”) per share (or its equivalent) as
of the reporting date in accordance with the “practical expedient”
provisions related to investments in certain entities that
calculate net asset value per share (or its equivalent) included in
FASB ASC 820 for all
entities. As of June
30, 2022, the Company's investment balance in the CREO was
$6,653.
Wind Down of the Company's GCF Repo Business
Since 2017, the Company has carried
out a matched book GCF repo business as a full netting member of
the FICC Government Services Division. In October 2021, primarily due to reduced
spreads in the repo market for GCF collateral, the Company
decided to wind down this business. As of December 31, 2021, the wind down was
completed and the GCF reverse repurchase agreements and
repurchase agreements balances were reduced to zero. See note
10.
INSU Acquisition Corp III ("Insurance
SPAC III")
The Operating LLC is the manager of Insurance Acquisition
Sponsor III, LLC (“IAS III”) and Dioptra Advisors III, LLC
(together with IAS III, the “Insurance SPAC III Sponsor Entities”).
The Insurance SPAC III Sponsor Entities are sponsors of INSU
Acquisition Corp. III ("Insurance SPAC III"). On December 22 2020, Insurance SPAC III
completed the sale of 25,000,000 units (the “Insurance SPAC III
Units”) in its initial public offering, which
included 3,200,000 units issued pursuant to the underwriters’
over-allotment option.
Each Insurance SPAC III
Unit consists of one
share of Insurance SPAC III's Class A common stock, par value
$0.0001 per share (“Insurance SPAC III Common Stock”), and
one-third of one Insurance SPAC III warrant (each, an
“Insurance SPAC III Warrant”), where each whole Insurance
SPAC III Warrant entitles the holder to purchase one share of Insurance SPAC III
Common Stock for $11.50 per share. The Insurance SPAC III Units
were sold in the IPO at an offering price of $10.00 per Unit, for
gross proceeds of $250,000 (before underwriting discounts and
commissions and offering expenses). Pursuant to the underwriting
agreement in the IPO, Insurance SPAC III granted the
underwriters in the IPO (the “Insurance SPAC III
Underwriters”) a 45-day option to purchase up to 3,270,000
additional Insurance SPAC III Units solely to cover
over-allotments, if any; and on December
21, 2020, the Insurance SPAC III Underwriters
notified the Company that they were partially exercising the
over-allotment option for 3,200,000 Insurance SPAC III Units and
waiving the remainder of the over-allotment option. Immediately
following the completion of the IPO, there were an aggregate of
34,100,000 shares of Insurance SPAC III Common Stock issued
and outstanding. If the Insurance SPAC III fails to
consummate a business combination within the first 24
months following the IPO, its corporate existence will cease except
for the purposes of winding up its affairs and liquidating its
assets.
The Insurance SPAC III Sponsor Entities purchased an aggregate of
575,000 of placement units in Insurance SPAC III in a private
placement that occurred simultaneously with the IPO for an
aggregate of $5,750, or $10.00 per placement unit. Each placement
unit consists of one share of
Insurance SPAC III Common Stock and one-third of
one warrant (the “Insurance SPAC
III Placement Warrant”). The Insurance SPAC III placement units are
identical to the Insurance SPAC III Units sold in the IPO except
(i) the shares of Insurance SPAC III Common Stock issued as part of
the placement units and the Insurance SPAC III Warrants will
not be redeemable by Insurance SPAC
III, (ii) the Insurance SPAC III Warrants may be exercised by the holders on a cashless
basis, and (iii) the shares of Insurance SPAC III Common Stock
issued as part of the placement units, together with the Insurance
SPAC III Warrants, are entitled to certain registration rights.
Subject to certain limited exceptions, the placement units
(including the underlying Insurance SPAC III Warrants and Insurance
SPAC III Common Stock and the shares of Insurance SPAC III Common
Stock issuable upon exercise of the Insurance SPAC III Warrants)
will not be transferable,
assignable or salable until 30 days
after the completion of the Insurance SPAC III’s initial business
combination.
A total of $250,000 of the net proceeds from the private
placement and the IPO (including approximately $10,600 of the
deferred underwriting commission from the IPO) were placed in a
trust account. Except for the withdrawal of interest to pay taxes
(or dissolution expenses if a business combination is not consummated), none of the funds held in the trust account
will be released until the earlier of (i) the completion of
Insurance SPAC III’s initial business combination, (ii) in
connection with a stockholder vote to amend Insurance SPAC III’s
amended and restated certificate of incorporation (A) to modify the
substance or timing of Insurance SPAC III’s obligation to redeem
100% of its public shares if it does not complete an initial business combination
within 24 months from the
completion of the IPO or (B) with respect to any other provision
relating to stockholders’ rights or pre-initial business
combination activity, or (iii) the redemption of all of
Insurance SPAC III’s public shares issued in the IPO if the
Insurance SPAC III is unable to consummate an initial business
combination within 24 months from
the completion of the IPO. If Insurance SPAC III does
not complete a business combination
within the first 24 months following the IPO, the placement
units will expire worthless.
The Insurance SPAC III Sponsor Entities collectively hold 8,525,000
founder shares in Insurance SPAC III. Subject to certain
limited exceptions, the founder shares will not be transferable or salable except (a)
with respect to 25% of such shares, until consummation of a
business combination, and (b) with respect to additional 25% tranches of such shares, when the closing
price of Insurance SPAC III Common Stock exceeds $12.00, $13.50,
and $17.00, respectively, for 20
out of any 30 consecutive trading
days following the consummation of a business combination. Certain
non-controlling interests in the Insurance SPAC III Sponsor
Entities, including executive and key employees of the Operating
LLC, purchased membership interests in the Insurance SPAC III
Sponsor Entities and, in addition to having an interest in
Insurance SPAC III’s placement units discussed above, have an
interest in Insurance SPAC III’s founder shares through such
membership interests in the Insurance SPAC III Sponsor Entities.
The number of the Insurance SPAC III’s founder shares in which
such non-controlling interests in the Insurance SPAC III Sponsor
Entities, including such executives and key employees of the
Operating LLC, have an interest in through the Insurance SPAC III
Sponsor Entities will not be
finally and definitively determined until consummation of a
business combination. The number of Insurance SPAC III’s founder
shares currently allocated to the Operating LLC is 4,267,500, but
such number of founder shares will also not be finally and definitively determined
until the consummation of a business combination.
The Operating LLC loaned to Insurance SPAC III approximately
$71 to cover IPO expenses, which was repaid in full at the
closing of the IPO. Insurance Acquisition Sponsor III and its
affiliates, including the Operating LLC, have also committed to
loan Insurance SPAC III up to an additional $1,500 to cover
operating and acquisition related expenses following the IPO, of
which $960 was borrowed by Insurance SPAC III as
of June 30, 2022. See
notes 24 and 25. These loans will bear no interest and, if Insurance SPAC III
consummates a business combination in the required timeframe, the
loans are to be repaid from the funds held in Insurance SPAC III’s
trust account. If Insurance SPAC III does not consummate a business combination in the
required timeframe, no funds from
Insurance SPAC III's trust account can be used to repay the
loans.
As of June 30, 2022, the
Company had a total equity method investment in Insurance
SPAC III of $3,586, which was included as a component of investment
in equity method affiliates in its consolidated balance
sheet. Partially offsetting this amount was non-controlling
interest of $4,325, which was included as a component of
non-controlling interest in the Company's consolidated balance
sheet. Therefore, the net carrying value of the
Company's investment in Insurance SPAC III (excluding its
advances under its loan agreement) was $(739) as of June 30, 2022.
5. NET TRADING
Net trading consisted of the following in the periods
presented.
NET TRADING
|
(Dollars in Thousands)
|
|
|
Three Months
Ended
|
|
|
Six Months
Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
Net realized gains (losses) - trading inventory
|
|
$ |
5,112 |
|
|
$ |
(2,786 |
) |
|
$ |
9,727 |
|
|
$ |
15,115 |
|
Net unrealized gains (losses) - trading inventory
|
|
|
(2,927 |
) |
|
|
7,467 |
|
|
|
(6,190 |
) |
|
|
(4,087 |
) |
Net gains and losses
|
|
|
2,185 |
|
|
|
4,681 |
|
|
|
3,537 |
|
|
|
11,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income- trading inventory
|
|
|
745 |
|
|
|
1,709 |
|
|
|
1,836 |
|
|
|
3,465 |
|
Interest income-reverse repos
|
|
|
12,303 |
|
|
|
20,056 |
|
|
|
28,002 |
|
|
|
39,391 |
|
Interest income
|
|
|
13,048 |
|
|
|
21,765 |
|
|
|
29,838 |
|
|
|
42,856 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense-repos
|
|
|
(7,561 |
) |
|
|
(10,275 |
) |
|
|
(15,223 |
) |
|
|
(20,387 |
) |
Interest expense-margin payable
|
|
|
(415 |
) |
|
|
(202 |
) |
|
|
(608 |
) |
|
|
(393 |
) |
Interest expense
|
|
|
(7,976 |
) |
|
|
(10,477 |
) |
|
|
(15,831 |
) |
|
|
(20,780 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other trading
revenue
|
|
|
3,120 |
|
|
|
2,430 |
|
|
|
4,855 |
|
|
|
4,478 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net trading
|
|
$ |
10,377 |
|
|
$ |
18,399 |
|
|
$ |
22,399 |
|
|
$ |
37,582 |
|
Trading inventory includes investments classified as
investments-trading as well as trading securities sold, not yet purchased. See note
7. For discussion of margin
payable, see note 6. Other
trading revenue includes revenue earned on our agency repo
business (see note 10).
6. RECEIVABLES FROM AND PAYABLES
TO BROKERS, DEALERS, AND CLEARING AGENCIES
Amounts receivable from brokers, dealers, and clearing agencies
consisted of the following.
RECEIVABLES FROM BROKERS, DEALERS, AND CLEARING AGENCIES
|
(Dollars in Thousands)
|
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
Deposits with clearing agencies
|
|
$ |
250 |
|
|
$ |
250 |
|
Unsettled regular way trades, net
|
|
|
12,556 |
|
|
|
2,827 |
|
Receivables from clearing agencies
|
|
|
128,992 |
|
|
|
65,315 |
|
Receivables from brokers, dealers, and clearing agencies
|
|
$ |
141,798 |
|
|
$ |
68,392 |
|
Amounts payable to brokers, dealers, and clearing agencies
consisted of the following.
PAYABLES TO BROKERS, DEALERS, AND CLEARING AGENCIES
|
(Dollars in Thousands)
|
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
Margin payable
|
|
$ |
137,877 |
|
|
$ |
160,896 |
|
Payables to brokers, dealers, and clearing agencies
|
|
$ |
137,877 |
|
|
$ |
160,896 |
|
Deposits with clearing agencies represent contractual amounts the
Company is required to deposit with its clearing agents.
Securities transactions that settle in the regular way are recorded
on the trade date, as if they had settled. The related amounts
receivable and payable for unsettled securities transactions are
recorded net in receivables from or payables to brokers, dealers,
and clearing agencies on the Company’s consolidated balance
sheets.
Receivables from clearing agencies are primarily comprised of cash
received by the Company upon execution of short trades that is
restricted from withdrawal by the clearing agent.
Margin payable represents amounts borrowed from Pershing, LLC and
Cantor Fitzgerald to finance the Company’s trading
portfolio. See note 5 for
interest expense incurred on margin payable. All of the
Company's securities included in investments-trading and a portion
of the Company's securities included in other investments, at fair
value serve as collateral for this margin loan. See note
7.
7. FINANCIAL INSTRUMENTS
Investments—Trading
Investments-trading consisted of the following.
INVESTMENTS - TRADING
|
(Dollars in Thousands)
|
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
U.S. government agency MBS and CMOs
|
|
$ |
110,541 |
|
|
$ |
134,093 |
|
U.S. government agency debt securities
|
|
|
27,435 |
|
|
|
22,373 |
|
RMBS
|
|
|
7 |
|
|
|
9 |
|
U.S. Treasury securities
|
|
|
9,063 |
|
|
|
- |
|
ABS
|
|
|
1 |
|
|
|
1 |
|
Corporate bonds and redeemable preferred stock
|
|
|
47,856 |
|
|
|
45,519 |
|
Foreign government bonds
|
|
|
187 |
|
|
|
467 |
|
Municipal bonds
|
|
|
1,767 |
|
|
|
18,841 |
|
Certificates of deposit
|
|
|
- |
|
|
|
169 |
|
Derivatives
|
|
|
4,189 |
|
|
|
1,275 |
|
Equity securities
|
|
|
878 |
|
|
|
1,118 |
|
Investments-trading
|
|
$ |
201,924 |
|
|
$ |
223,865 |
|
Trading Securities Sold, Not Yet
Purchased
Trading securities sold, not yet
purchased consisted of the following.
TRADING SECURITIES SOLD, NOT YET
PURCHASED
|
(Dollars in Thousands)
|
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
U.S. government
agency debt securities
|
|
$ |
1 |
|
|
$ |
1 |
|
U.S. Treasury securities
|
|
|
83,416 |
|
|
|
29,513 |
|
Corporate bonds and redeemable preferred stock
|
|
|
55,248 |
|
|
|
32,574 |
|
Derivatives
|
|
|
2,884 |
|
|
|
424 |
|
Trading securities sold, not yet purchased
|
|
$ |
141,549 |
|
|
$ |
62,512 |
|
The Company manages its exposure to changes in interest rates for
the interest rate sensitive securities it holds by entering into
offsetting short positions for similar fixed rate securities. See
note 5 for realized and unrealized
gains recognized on investments-trading.
Other Investments, at Fair Value
Other investments, at fair value consisted of the following.
OTHER INVESTMENTS, AT FAIR VALUE
|
(Dollars in Thousands)
|
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
Equity securities
|
|
|
20,089 |
|
|
$ |
27,104 |
|
Restricted equity securities
|
|
|
6,385 |
|
|
|
17,078 |
|
Corporate bonds and redeemable preferred stock
|
|
|
476 |
|
|
|
476 |
|
CREO
|
|
|
6,653 |
|
|
|
5,830 |
|
U.S. Insurance JV
|
|
|
3,338 |
|
|
|
3,450 |
|
SPAC Fund
|
|
|
506 |
|
|
|
1,980 |
|
Residential loans
|
|
|
111 |
|
|
|
115 |
|
Other investments, at fair value
|
|
$ |
37,558 |
|
|
$ |
56,033 |
|
A total of
$11,863 and $15,563 of the amounts shown as other
investments, at fair value above serve as collateral for the
Company's margin loan payable as of June 30, 2022 and December 31, 2021, respectively. See
note 6.
Other Investments, Sold Not Yet
Purchased
Other investments, sold not yet
purchased consisted of the following.
OTHER INVESTMENTS SOLD, NOT YET
PURCHASED
|
(Dollars in Thousands)
|
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
Equity securities
|
|
$ |
128 |
|
|
$ |
2,488 |
|
Other investments sold, not yet purchased
|
|
$ |
128 |
|
|
$ |
2,488 |
|
8. FAIR VALUE
DISCLOSURES
Fair Value Option
The Company has elected to account for certain of its other
financial assets at fair value under the fair value option
provisions of FASB ASC 825. The
primary reason for electing the fair value option was to reduce the
burden of monitoring the differences between the cost and the fair
value of the Company’s investments, previously classified as
available for sale securities, including the assessment as to
whether the declines are temporary in nature and to further remove
an element of management judgment.
Such financial assets accounted for at fair value include:
|
●
|
securities that would otherwise qualify for available for sale
treatment;
|
|
●
|
investments in equity method affiliates that have the attributes in
FASB ASC 946-10-15-2
(commonly referred to as investment companies); and
|
|
●
|
investments in residential loans.
|
The changes in fair value (realized and unrealized gains and
losses) of these instruments for which the Company has elected the
fair value option are recorded in principal transactions and other
income in the consolidated statements of operations. All of the
investments for which the Company has elected the fair value option
are included as a component of other investments, at fair value in
the consolidated balance sheets.
The Company recognized net
gains (losses) related to changes in fair value of investments that
are included as a component of other investments, at fair value
during the three months
ended June 30, 2022 and
2021 of $(7,019) and $(11,953), respectively. The Company
recognized net gains (losses) related to changes in fair value of
investments that are included as a component of other investments,
at fair value during the six months
ended June 30, 2022 and
June 30, 2021 of $(25,737) and $67,236,, respectively.
The Company recognized net
gains (losses) related to changes in fair value of investments that
are included as a component of other investments, sold not yet purchased during the three months ended June 30, 2022 and 2021 of $79 and $714, respectively. The
Company recognized net gains (losses) related to changes in fair
value of investments that are included as a component of other
investments, sold not yet purchased
during the six months ended
June 30, 2022 and June 30, 2021 of $257 and $776,
respectively.
Fair Value Measurements
In accordance with FASB ASC 820,
the Company has categorized its financial instruments, based on the
priority of the inputs to the valuation technique, into a
three level valuation hierarchy.
The valuation hierarchy gives the highest priority to unadjusted
quoted prices in active markets for identical assets or liabilities
(level 1 measurement) and the
lowest priority to unobservable inputs (level 3 measurement). The three levels of the valuation hierarchy under
FASB ASC 820 are described
below.
Level 1 Financial
assets and liabilities with values that are based on
unadjusted quoted prices in active markets that are accessible at
the measurement date for identical, unrestricted assets or
liabilities.
Level 2
Financial assets and liabilities with values that are based on
one or more of the following:
|
1.
|
Quoted prices for similar assets or liabilities in active
markets;
|
|
2.
|
Quoted prices for identical or similar assets or liabilities in
non-active markets;
|
|
3.
|
Pricing models whose inputs are derived, other than quoted prices,
are observable for substantially the full term of the asset or
liability; or
|
|
4.
|
Pricing models whose inputs are derived principally from or
corroborated by observable market data through correlation or
other means for substantially the full term of the asset or
liability.
|
Level 3 Financial
assets and liabilities with values that are based on prices or
valuation techniques that require inputs that are both significant
to the fair value measurement and unobservable. These inputs
reflect management’s own assumptions about the assumptions a market
participant would use in pricing the asset or liability.
In certain cases, the inputs used to measure fair value may fall into different levels of the
valuation hierarchy. In such cases, the level in the valuation
hierarchy within which the fair value measurement in its entirety
falls has been determined based on the lowest level input that is
significant to the fair value measurement in its entirety. The
Company’s assessment of the significance of a particular input to
the fair value measurement in its entirety requires judgment and
considers factors specific to the asset or liability.
Both observable and unobservable inputs may be used to determine the fair value of
positions that the Company has classified within the level
3 category. As a result, the
unrealized gains and losses for assets and liabilities within the
level 3 category presented in the
tables below may include changes in
fair value that were attributable to both observable (e.g., changes
in market interest rates) and unobservable (e.g., changes in
unobservable long-dated volatilities) inputs.
The following tables present information about the Company’s assets
and liabilities measured at fair value as of June 30, 2022 and December 31, 2021 and indicates the valuation
hierarchy of the valuation techniques utilized by the Company to
determine such fair value.
FAIR VALUE MEASUREMENTS ON A RECURRING BASIS
|
June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
Significant
|
|
|
Significant
|
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
Observable
|
|
|
Unobservable
|
|
|
|
|
|
|
|
Active Markets
|
|
|
Inputs
|
|
|
Inputs
|
|
Assets
|
|
Fair Value
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
Investments-trading:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government agency MBS and CMOs
|
|
$ |
110,541 |
|
|
$ |
- |
|
|
$ |
110,541 |
|
|
$ |
- |
|
U.S. government agency debt securities
|
|
|
27,435 |
|
|
|
- |
|
|
|
27,435 |
|
|
|
- |
|
RMBS
|
|
|
7 |
|
|
|
- |
|
|
|
7 |
|
|
|
- |
|
U.S. Treasury securities
|
|
|
9,063 |
|
|
|
9,063 |
|
|
|
- |
|
|
|
- |
|
ABS
|
|
|
1 |
|
|
|
- |
|
|
|
1 |
|
|
|
- |
|
Corporate bonds and redeemable preferred stock
|
|
|
47,856 |
|
|
|
- |
|
|
|
47,856 |
|
|
|
- |
|
Foreign government bonds
|
|
|
187 |
|
|
|
- |
|
|
|
187 |
|
|
|
- |
|
Municipal bonds
|
|
|
1,767 |
|
|
|
- |
|
|
|
1,767 |
|
|
|
- |
|
Derivatives
|
|
|
4,189 |
|
|
|
- |
|
|
|
4,189 |
|
|
|
- |
|
Equity securities
|
|
|
878 |
|
|
|
- |
|
|
|
878 |
|
|
|
- |
|
Total investments - trading
|
|
$ |
201,924 |
|
|
$ |
9,063 |
|
|
$ |
192,861 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other investments, at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
$ |
20,089 |
|
|
$ |
20,089 |
|
|
$ |
- |
|
|
$ |
- |
|
Restricted equity securities
|
|
|
6,385 |
|
|
|
- |
|
|
|
6,385 |
|
|
|
- |
|
Corporate bonds and redeemable preferred stock
|
|
|
476 |
|
|
|
- |
|
|
|
476 |
|
|
|
- |
|
Residential loans
|
|
|
111 |
|
|
|
- |
|
|
|
111 |
|
|
|
- |
|
|
|
|
27,061 |
|
|
$ |
20,089 |
|
|
$ |
6,972 |
|
|
$ |
- |
|
Investments measured at NAV (1)
|
|
|
10,497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other investments, at fair value
|
|
$ |
37,558 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading securities sold, not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government agency debt securities
|
|
$ |
1 |
|
|
$ |
- |
|
|
$ |
1 |
|
|
$ |
- |
|
U.S. Treasury securities
|
|
|
83,416 |
|
|
|
83,416 |
|
|
|
- |
|
|
|
- |
|
Corporate bonds and redeemable preferred stock
|
|
|
55,248 |
|
|
|
- |
|
|
|
55,248 |
|
|
|
- |
|
Derivatives
|
|
|
2,884 |
|
|
|
- |
|
|
|
2,884 |
|
|
|
- |
|
Total trading
securities sold, not yet purchased
|
|
$ |
141,549 |
|
|
$ |
83,416 |
|
|
$ |
58,133 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other investments, sold not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
securities
|
|
$ |
128 |
|
|
$ |
128 |
|
|
$ |
- |
|
|
$ |
- |
|
Total other investments sold, not yet purchased
|
|
$ |
128 |
|
|
$ |
128 |
|
|
$ |
- |
|
|
$ |
- |
|
(1)
|
As a practical expedient, the Company uses NAV (or its equivalent)
to measure the fair value of its investments in the U.S. Insurance
JV, the SPAC Fund and the CREO JV. The U.S. Insurance JV
invests in USD denominated debt issued by small insurance and
reinsurance companies. The SPAC Fund invests in
equity securities of SPACs. The CREO JV invests in primarily
multi-family commercial real estate mortgage-backed loans and
below-investment grade rated tranches in CRE CLOs collateralized by
mostly transitional commercial real estate mortgage-backed loans.
See note 4. According to ASC
820, these investments are
not categorized within the
valuation hierarchy.
|
FAIR VALUE MEASUREMENTS ON A RECURRING BASIS
|
December 31, 2021 |
(Dollars in Thousands)
|
|
|
|
|
|
|
|
|
|
|
Significant
|
|
|
Significant
|
|
|
|
|
|
|
|
Quoted Prices in
|
|
|
Observable
|
|
|
Unobservable
|
|
|
|
|
|
|
|
Active Markets
|
|
|
Inputs
|
|
|
Inputs
|
|
Assets
|
|
Fair Value
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
Investments-trading:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government agency MBS and CMOs
|
|
$ |
134,093 |
|
|
$ |
- |
|
|
$ |
134,093 |
|
|
$ |
- |
|
U.S. government agency debt securities
|
|
|
22,373 |
|
|
|
- |
|
|
|
22,373 |
|
|
|
- |
|
RMBS
|
|
|
9 |
|
|
|
- |
|
|
|
9 |
|
|
|
- |
|
U.S. Treasury securities
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
ABS
|
|
|
1 |
|
|
|
- |
|
|
|
1 |
|
|
|
- |
|
Corporate bonds and redeemable preferred stock
|
|
|
45,519 |
|
|
|
- |
|
|
|
45,519 |
|
|
|
- |
|
Foreign government bonds
|
|
|
467 |
|
|
|
- |
|
|
|
467 |
|
|
|
- |
|
Municipal bonds
|
|
|
18,841 |
|
|
|
- |
|
|
|
18,841 |
|
|
|
- |
|
Certificates of deposit
|
|
|
169 |
|
|
|
- |
|
|
|
169 |
|
|
|
- |
|
Derivatives
|
|
|
1,275 |
|
|
|
- |
|
|
|
1,275 |
|
|
|
- |
|
Equity securities
|
|
|
1,118 |
|
|
|
- |
|
|
|
1,118 |
|
|
|
- |
|
Total investments - trading
|
|
$ |
223,865 |
|
|
$ |
- |
|
|
$ |
223,865 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other investments, at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Securities
|
|
$ |
27,104 |
|
|
$ |
27,104 |
|
|
$ |
- |
|
|
$ |
- |
|
Restricted Equity
Securities
|
|
|
17,078 |
|
|
|
- |
|
|
|
17,078 |
|
|
|
- |
|
Corporate bonds and
redeemable preferred stock
|
|
|
476 |
|
|
|
- |
|
|
|
476 |
|
|
|
- |
|
Residential loans
|
|
|
115 |
|
|
|
- |
|
|
|
115 |
|
|
|
- |
|
|
|
|
44,773 |
|
|
$ |
27,104 |
|
|
$ |
17,669 |
|
|
$ |
- |
|
Investments measured at NAV (1)
|
|
|
11,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other investments, at fair value
|
|
$ |
56,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading securities sold, not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities
|
|
$ |
29,513 |
|
|
$ |
29,513 |
|
|
$ |
- |
|
|
$ |
- |
|
Corporate bonds and redeemable preferred stock
|
|
|
32,574 |
|
|
|
- |
|
|
|
32,574 |
|
|
|
- |
|
US Government Agency debt
|
|
|
1 |
|
|
|
1 |
|
|
|
- |
|
|
|
- |
|
Derivatives
|
|
|
424 |
|
|
|
- |
|
|
|
424 |
|
|
|
- |
|
Total trading
securities sold, not yet purchased
|
|
$ |
62,512 |
|
|
$ |
29,514 |
|
|
$ |
32,998 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other investments, sold not yet purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
securities
|
|
$ |
2,488 |
|
|
$ |
2,488 |
|
|
$ |
- |
|
|
$ |
- |
|
Total other investments sold, not yet purchased
|
|
$ |
2,488 |
|
|
$ |
2,488 |
|
|
$ |
- |
|
|
$ |
- |
|
(1)
|
As a practical expedient, the Company uses NAV (or its equivalent)
to measure the fair value of its investments in the U.S. Insurance
JV, the SPAC Fund and the CREO JV. The U.S. Insurance JV
invests in USD denominated debt issued by small insurance and
reinsurance companies. The SPAC Fund invests in
equity securities of SPACs. The CREO JV invests in primarily
multi-family commercial real estate mortgage-backed loans and
below-investment grade rated tranches in CRE CLOs collateralized by
mostly transitional commercial real estate mortgage-backed loans.
See note 4. According to ASC
820, these investments are
not categorized within the
valuation hierarchy.
|
The following provides a brief description of the types of
financial instruments the Company holds, the methodology for
estimating fair value, and the level within the valuation hierarchy
of the estimate. The discussion that follows applies regardless of
whether the instrument is included in investments-trading; other
investments, at fair value; or trading securities sold, not yet purchased.
U.S. Government Agency
MBS and CMOs: These are securities that are generally traded
over-the-counter. The Company generally values these securities
using third party quotations such
as unadjusted broker-dealer quoted prices or market price
quotations from third party pricing
services. These valuations are based on a market approach. The
Company classifies the fair value of these securities within level
2 of the valuation hierarchy.
U.S. Government Agency
Debt Securities: Callable and non-callable U.S. government
agency debt securities are measured primarily based on quoted
market prices obtained from third
party pricing services. Non-callable U.S. government agency debt
securities are generally classified within level 1 and callable U.S. government agency debt
securities are classified within level 2 of the valuation hierarchy.
RMBS: The Company
generally values these securities using third party quotations such as unadjusted
broker-dealer quoted prices or market price quotations from
third party pricing services. These
valuations are based on a market approach. The Company generally
classifies the fair value of these securities based on third party quotations within level
2 of the valuation hierarchy.
U.S. Treasury
Securities: U.S. Treasury securities include U.S. Treasury
bonds and notes and the fair values of the U.S. Treasury securities
are based on quoted prices or market activity in active markets.
Valuation adjustments are not
applied. The Company classifies the fair value of these securities
within level 1 of the valuation
hierarchy.
CLOS, CDOs, and
ABS: CLOs, CDOs, and ABS are interests in securitizations.
ABS may include, but are not limited to, securities backed by auto
loans, credit card receivables, or student loans. When the Company
is able to obtain independent market quotations from at least
two broker-dealers and where a
price within the range of at least two broker-dealers is used or market price
quotations from third party pricing
services is used, these interests in securitizations will generally
be classified within level 2 of the
valuation hierarchy. These valuations are based on a market
approach. The independent market quotations from broker-dealers are
generally nonbinding. The Company seeks quotations from
broker-dealers that historically have actively traded, monitored,
issued, and been knowledgeable about the interests in
securitizations. The Company generally believes to the extent that
it (i) receives two
quotations in a similar range from broker-dealers knowledgeable
about these interests in securitizations and (ii) considers
the broker-dealers gather and utilize observable market information
such as new issue activity in the primary market, trading activity
in the secondary market, credit spreads versus historical levels,
bid-ask spreads, and price consensus among market participants and
sources, then classification within level 2 of the valuation hierarchy is appropriate.
In the absence of two broker-dealer
market quotations, a single broker-dealer market quotation
may be used without corroboration
of the quote in which case the Company generally classifies the
fair value within level 3 of the
valuation hierarchy.
If quotations are unavailable, prices observed by the Company for
recently executed market transactions or valuation models prepared
by the Company’s management may be
used, which are based on an income approach. These models prepared
by the Company’s management include estimates, and the valuations
derived from them could differ materially from amounts realizable
in an open market exchange. Each CLO and CDO position is evaluated
independently taking into consideration available comparable market
levels, underlying collateral performance and pricing, deal
structures, and liquidity. Fair values based on internal
valuation models prepared by the Company’s management are generally
classified within level 3 of the
valuation hierarchy.
Establishing fair value is inherently subjective (given the
volatile and sometimes illiquid markets for certain interests in
securitizations) and requires management to make a number of
assumptions, including assumptions about the future of interest
rates, discount rates, and the timing of cash flows. The
assumptions the Company applies are specific to each security.
Although the Company may rely on
internal calculations to compute the fair value of certain interest
in securitizations, the Company requests and considers indications
of fair value from third party
pricing services to assist in the valuation process.
Corporate Bonds and
Redeemable Preferred Stock: The Company uses recently
executed transactions or third
party quotations from independent pricing services to arrive at the
fair value of its investments in corporate bonds and redeemable
preferred stock. These valuations are based on a market approach.
The Company generally classifies the fair value of these bonds
within level 2 of the valuation
hierarchy. In instances where the fair values of securities are
based on quoted prices in active markets (for example with
redeemable preferred stock), the Company classifies the fair value
of these securities within level 1
of the valuation hierarchy.
Foreign Government
Bonds: The fair value of foreign government bonds is
estimated using valuations provided by third party pricing services and classifies
the fair value within level 2 of
the valuation hierarchy.
Municipal Bonds:
Municipal bonds, which include obligations of U.S. states,
municipalities, and political subdivisions, primarily include bonds
or notes issued by U.S. municipalities. The Company generally
values these securities using third
party quotations such as market price quotations from third party pricing services. The Company
generally classifies the fair value of these bonds within level
2 of the valuation hierarchy. The
valuations are based on a market approach. In instances where the
Company is unable to obtain reliable market price quotations from
third party pricing services, the
Company will use its own internal valuation models. In these cases,
the Company will classify such securities as level 3 within the valuation hierarchy until it is
able to obtain third party
pricing.
Certificates of
Deposit: The fair value of certificates of deposit is
estimated using valuations provided by third party pricing services. The Company
classifies the fair value of certificates of deposit within level
2 of the valuation hierarchy.
Residential Loans:
Management utilizes home price indices or market indications to
value the residential loans. The Company classifies the
fair value of these loans within level 2 in the valuation hierarchy.
Equity Securities:
The fair value of equity securities that represent unrestricted
investments in publicly traded companies (common or preferred
shares, options, warrants, and other equity investments) are
determined using the closing price of the security as of the
reporting date. These are securities that are traded on a
recognized liquid exchange and the Company classifies their fair
value within level 1 of the
valuation hierarchy. The fair value of equity securities that
represent investments in privately held companies are generally
determined either (i) based on a valuation model or (ii) based on
recently observed transactions in the same instrument or similar
instrument that we hold. These valuations are generally
classified within either level 2 or
level 3 of the valuation
hierarchy.
Restricted Equity
Securities: Restricted equity securities are
investments in publicly traded companies. However, they are
restricted from re-sale until either (a) the share price
trades above a certain threshold for a certain period of time; or
(b) a certain period of time elapses or both. The Company
determines the fair value by utilizing a model that starts with the
publicly traded share price but then applies a discount based on a
Monte Carlo simulation. The inputs to this model are
observable so the Company classifies these securities within
level 2 of the valuation
hierarchy. The Company is not
allowed to sell these shares during the restriction period and
there is no certainty as to when
these hurdles will be met or if they will be met at all.
Subordinated
Notes: The Company uses recently executed transactions
or third-party quotations from
independent pricing services to arrive at the fair value of its
investments in subordinated notes. These valuations are based on a
market approach. The Company generally classifies the fair value of
these bonds within level 2 of the
valuation hierarchy.
Derivatives
TBAs and Other Forward Agency MBS Contracts
The Company generally values these securities using third party quotations such as unadjusted
broker-dealer quoted prices or market price quotations from
third party pricing services. TBAs
and other forward agency MBS contracts are generally classified
within level 2 of the valuation
hierarchy. If there is limited transaction activity or less
transparency to observe market based inputs to valuation models,
TBAs and other forward agency MBS contracts are classified within
level 3 of the valuation
hierarchy. U.S. government agency MBS and CMOs include
TBAs and other forward agency MBS contracts. Unrealized
gains on TBAs and other forward agency MBS contracts are included
in investments-trading on the Company’s consolidated balance sheets
and unrealized losses on TBAs and other forward agency MBS
contracts are included in trading securities sold, not yet purchased on the Company’s
consolidated balance sheets. See note 9.
Other Extended Settlement Trades
When the Company buys or sells a financial instrument that will
not settle in the regular
timeframe, the Company will account for that purchase or sale on
the settlement date rather than the trade date. In those
cases, the Company accounts for the transaction between trade date
and settlement date as a derivative (as either a purchase
commitment or sale commitment). The Company will record an
unrealized gain or unrealized loss on the derivative for the
difference between the fair value of the underlying financial
instrument as of the reporting date and the agreed upon transaction
price. The Company will determine the fair value of the
financial instrument using the methodologies described above.
Equity Derivatives
The Company enters into equity derivatives such as puts and short
call options. These are securities that are traded on a
recognized liquid exchange and the Company classifies their fair
value within level 1 of the
valuation hierarchy.
Foreign Currency Forward Contracts
Foreign currency forward contracts are exchange-traded derivatives,
which transact on an exchange that is deemed to be
active. The fair value of the foreign currency forward
contracts is based on current quoted market
prices. Valuation adjustments are not applied. These are classified
within level 1 of the valuation
hierarchy. See note 9.
Investments in Certain Entities that Calculate NAV Per Share (or
its Equivalent)
The following table presents additional information about
investments in certain entities that calculate NAV per share
(regardless of whether the “practical expedient” provisions of FASB
ASC 820 have been applied), which
are measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021.
|
|
Fair Value
|
|
|
Unfunded Commitments
|
|
|
Redemption Frequency
|
|
|
Redemption Notice Period
|
|
|
|
June 30, 2022
|
|
|
|
|
|
|
|
|
|
|
Other investments, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CREO (a)
|
|
$ |
6,653 |
|
|
$ |
8,464 |
|
|
|
N/A |
|
|
|
N/A |
|
U.S. Insurance JV
(b)
|
|
|
3,338 |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
SPAC Fund (c)
|
|
|
506 |
|
|
|
N/A |
|
|
Quarterly after 1 year lock up
|
|
|
30 days
|
|
|
|
$ |
10,497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value
|
|
|
Unfunded Commitments
|
|
|
Redemption Frequency
|
|
|
Redemption Notice Period
|
|
|
|
December 31, 2021
|
|
|
|
|
|
|
|
|
|
|
Other investments, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CREO (a)
|
|
$ |
5,830 |
|
|
$ |
9,170 |
|
|
|
N/A |
|
|
|
N/A |
|
U.S. Insurance JV
(b)
|
|
|
3,450 |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
N/A |
|
SPAC Fund (c)
|
|
|
1,980 |
|
|
|
N/A |
|
|
Quarterly after 1 year lock up
|
|
|
30 days
|
|
|
|
$ |
11,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A |
Not Applicable |
|
(a) |
The
CREO JV invests in primarily multi-family commercial real estate
mortgage-backed loans and below-investment grade rated tranches in
CRE CLOs collateralized by mostly commercial real estate
mortgage-backed loans. See note 4. |
|
(b)
|
The U.S. Insurance JV invests in USD denominated debt issued by
small and medium size insurance and reinsurance
companies.
|
|
(c)
|
The SPAC Fund invests in equity interests of SPACs.
|
9. DERIVATIVE FINANCIAL
INSTRUMENTS
FASB ASC 815, Derivatives and
Hedging (“FASB ASC 815”),
provides for optional hedge accounting. When a derivative is deemed
to be a hedge and certain documentation and effectiveness testing
requirements are met, reporting entities can record all or a
portion of the change in the fair value of a designated hedge as an
adjustment to OCI rather than as a gain or loss in the statements
of operations. To date, the Company has not designated any derivatives as hedges
under the provisions included in FASB ASC 815.
All of the derivatives that the Company enters into contain master
netting arrangements. If certain requirements are met,
the offsetting provisions included in FASB ASC 210, Balance Sheet (“ASC 210”), allow (but do not require) the reporting entity to net the
asset and liability on the consolidated balance sheets. It is the
Company’s policy to present the derivative assets and liabilities
on a net basis if the conditions of ASC 210 are met. However, in general
the Company does not enter in
offsetting derivatives with the same
counterparties. Therefore, in all periods presented,
no derivatives are presented on a
net basis.
Derivative financial instruments are recorded at fair value. If the
derivative was entered into as part of the Company’s broker-dealer
operations, it will be included as a component of
investments-trading or trading securities sold, not yet purchased. If it is entered into as a
hedge for another financial instrument included in other
investments, at fair value then the derivative will be included as
a component of other investments, at fair value.
The Company may, from time to time,
enter into derivatives to manage its risk exposures arising from
(i) fluctuations in foreign currency rates with respect to the
Company’s investments in foreign currency denominated investments;
(ii) the Company’s investments in interest sensitive investments;
and (iii) the Company’s facilitation of mortgage-backed trading.
Derivatives entered into by the Company, from time to time,
may include (a) foreign
currency forward contracts; (b) purchase and sale agreements
of TBAs and other forward agency MBS contracts; and (c) other
extended settlement trades.
TBAs are forward contracts to purchase or sell MBS with collateral
that remains “to be announced” until just prior to the trade
settlement date. In addition to TBAs, the Company sometimes enters
into forward purchases or sales of agency MBS where the underlying
collateral has been identified. These transactions are
referred to as other forward agency MBS contracts. TBAs
and other forward agency MBS contracts are accounted for as
derivatives by the Company under ASC 815. The settlement of these
transactions is not expected to
have a material effect on the Company’s consolidated financial
statements.
In addition to TBAs and other forward agency MBS contracts as part
of the Company’s broker-dealer operations, the Company may from time to time enter into other
securities or loan trades that do not settle within the normal securities
settlement period. In those cases, the purchase or sale of the
security or loan is not recorded
until the settlement date. However, from the trade date
until the settlement date, the Company’s interest in the security
is accounted for as a derivative as either a forward purchase
commitment or forward sale commitment. The Company will
classify the related derivative either within investments-trading
or other investments, at fair value depending on where it intends
to classify the investment once the trade settles.
Derivatives involve varying degrees of off-balance sheet risk,
whereby changes in the level or volatility of interest rates or
market values of the underlying financial instruments may result in changes in the value of a
particular financial instrument in excess of its carrying amount.
Depending on the Company’s investment strategy, realized and
unrealized gains and losses are recognized in principal
transactions and other income or in net trading in the Company’s
consolidated statements of operations on a trade date basis.
The Company may, from time to time,
enter into the following derivative instruments.
Equity Derivatives
A significant portion of the Company’s equity holdings are carried
at fair value. The Company hedges a portion of this exposure
by entering into equity derivatives such as puts and short
call options from time to time. These derivative positions are
carried at fair value as a component of other investments, at fair
value and other investments sold, not yet purchased in the Company’s
consolidated balance sheets. As of June 30, 2022 and December 31, 2021, the Company had no put or short call options. From
time to time, the Company may also
enter into forward purchase commitments for equity
securities.
The Company also hedges a portion of the exposure from these equity
investments by entering into short trades. These short trades
are not treated as derivatives and
are carried as a component of other investments sold, not yet purchased. See Note 7.
TBAs and Other Forward Agency MBS Contracts
The Company enters into TBAs and other forward agency MBS
transactions for three main
reasons.